<?xml version="1.0" encoding="UTF-8"?>
<svg height="778.0" width="557.949" xmlns="http://www.w3.org/2000/svg">
 <g id="page" xmlns:svgx="http://www.xml-cml.org/schema/svgx">
  <path style="fill:none;stroke:rgb(0,0,0);stroke-width:1.0;" d="M62.360 53.720 L545.670 53.720 "/>
  <g begin="text">
   <text y="49.34" x="62.362,66.842,71.322,74.862,77.672,82.052,85.182,87.962,92.542,96.922,100.462,104.002,105.882,110.362,115.052,117.832,123.042,125.022,127.802,133.012,138.222,141.002,143.922,148.502,153.712,156.632" svgx:width="0.45,0.45,0.35,0.28,0.44,0.31,0.28,0.46,0.44,0.35,0.35,0.19,0.45,0.47,0.28,0.52,0.2,0.28,0.52,0.52,0.28,0.29,0.46,0.52,0.29,0.28" style="fill:rgb(0,0,0);font-family:GillSansStd-Italic;font-size:10.0px;stroke:none;">Poster session 2, 20 (s1) </text>
   <text y="49.34" x="530.672,535.672,540.672" svgx:width="0.5,0.5,0.5" style="fill:rgb(0,0,0);font-family:GillSansStd;font-size:10.0px;stroke:none;">443</text>
  </g>
  <g begin="text">
   <text y="768.0" x="355.802,363.932,368.622,370.502,373.312,375.192,380.092,381.972,386.352,389.132,393.712,397.562,399.442,403.822,406.952,411.432,414.972,416.852,420.392,423.172,425.572,430.052,434.742,437.872,442.562,447.252" svgx:width="0.81,0.47,0.19,0.28,0.19,0.49,0.19,0.44,0.28,0.46,0.38,0.19,0.44,0.31,0.45,0.35,0.19,0.35,0.28,0.24,0.45,0.47,0.31,0.47,0.47,0.19" style="fill:rgb(0,0,0);font-family:GillSansStd-Italic;font-size:10.0px;stroke:none;">Multiple Sclerosis Journal</text>
   <text y="768.0" x="449.132,451.912,456.912,461.912,466.912,471.912,474.102,476.882,481.882,486.882,489.072,491.852,495.082,499.662,504.662,507.892,510.672,515.672,520.672,525.672,530.672,535.672,540.672" svgx:width="0.28,0.5,0.5,0.5,0.5,0.22,0.28,0.5,0.5,0.22,0.28,0.32,0.46,0.5,0.32,0.28,0.5,0.5,0.5,0.5,0.5,0.5,0.5" style="fill:rgb(0,0,0);font-family:GillSansStd;font-size:10.0px;stroke:none;"> 2014; 20: (S1) 285–496</text>
  </g>
  <g begin="text">
   <text y="768.0" x="61.186,68.896,72.746,74.936,77.126,80.976,85.246,89.516,94.306,99.306,104.306,109.206,111.396,115.776,121.296" svgx:width="0.77,0.38,0.22,0.22,0.38,0.43,0.43,0.48,0.5,0.5,0.5,0.22,0.44,0.55,0.77" style="fill:rgb(0,0,0);font-family:GillSansStd;font-size:10.0px;stroke:none;">msj.sagepub.com</text>
  </g>
  <path style="fill:none;stroke:rgb(0,0,0);stroke-width:0.25;" d="M62.360 146.190 L129.860 146.190 "/>
  <path style="fill:none;stroke:rgb(0,0,0);stroke-width:0.44;" d="M62.360 717.190 L100.610 717.190 "/>
  <g begin="text">
   <text y="78.99" x="62.362,71.026,74.362,79.03,85.702,88.702,98.698,104.698,111.37,117.37,123.37,128.698,138.694,144.022,150.694,154.69,157.69,161.686,167.686,173.014,176.014,182.686,186.022,190.69,196.018,202.018,206.686,212.014,215.014,219.01,225.682,231.01,236.338,242.338,249.01,252.346,257.674" svgx:width="0.72,0.28,0.39,0.56,0.25,0.83,0.5,0.56,0.5,0.5,0.44,0.83,0.44,0.56,0.33,0.25,0.33,0.5,0.44,0.25,0.56,0.28,0.39,0.44,0.5,0.39,0.44,0.25,0.33,0.56,0.44,0.44,0.5,0.56,0.28,0.44,0.39" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:12.0px;stroke:none;">Risk management for disease therapies</text>
   <text y="111.99" x="62.362,67.861,72.361,76.861" svgx:width="0.61,0.5,0.5,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">P857</text>
   <text y="122.988" x="62.362,70.858,75.358,79.354,83.854,88.354,90.856,94.852,99.352,103.348,105.598,110.098,115.102,120.106,122.356,126.856,133.354,135.604,138.601,140.851,145.351,147.853,151.849,156.853,160.354,162.604,167.104,170.605,174.106,178.606,182.602,185.104,189.604,192.601,196.597,201.601,203.851,206.353,213.85,221.347,226.351,231.355,235.351" svgx:width="0.94,0.5,0.44,0.5,0.5,0.28,0.44,0.5,0.44,0.25,0.5,0.56,0.56,0.25,0.5,0.72,0.25,0.33,0.25,0.5,0.28,0.44,0.56,0.39,0.25,0.5,0.39,0.39,0.5,0.44,0.28,0.5,0.33,0.44,0.56,0.25,0.28,0.83,0.83,0.56,0.56,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Maraviroc and JC - virus associated immune </text>
   <text y="133.986" x="62.362,66.358,70.354,74.35,78.85,83.854,87.355,90.352,92.854,95.851,100.855,103.852,106.354,110.854,115.858,118.108,120.61,125.614,128.611,131.113,135.613,143.11,150.607,155.107,158.104,162.604,166.6,171.1,173.35,176.851,181.351,186.355,191.359,195.355,199.855,207.352" svgx:width="0.44,0.44,0.44,0.5,0.56,0.39,0.33,0.28,0.33,0.56,0.33,0.28,0.5,0.56,0.25,0.28,0.56,0.33,0.28,0.5,0.83,0.83,0.5,0.33,0.5,0.44,0.5,0.25,0.39,0.5,0.56,0.56,0.44,0.5,0.83,0.44" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">reconstitution inflammatory syndrome</text>
   <text y="144.984" x="62.362,67.861,70.111,75.61,80.11,84.61,89.11,91.612,94.114,97.615,99.865,105.868,110.368,114.364,117.361,120.862,125.362" svgx:width="0.61,0.25,0.61,0.5,0.5,0.5,0.28,0.28,0.39,0.25,0.67,0.5,0.44,0.33,0.39,0.5,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">L Zhovtis Ryerson</text>
   <text y="142.47" x="129.862" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="144.99" x="132.787,135.037,137.287,140.284,142.534,149.032,151.534,155.035,157.537,161.533" svgx:width="0.25,0.25,0.33,0.25,0.72,0.28,0.39,0.28,0.44,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, I Kister</text>
   <text y="142.47" x="164.529" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="144.99" x="167.454,169.704,171.954,175.455,177.705,184.203,188.199,191.196,195.696,199.692,202.689" svgx:width="0.25,0.25,0.39,0.25,0.72,0.44,0.33,0.5,0.44,0.33,0.28" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, J Herbert</text>
   <text y="142.47" x="205.191" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="153.468" x="62.363" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:5.85px;stroke:none;">1</text>
   <text y="155.99" x="65.287,71.29,76.294,82.792,85.042,90.046,94.546,99.046,103.546,108.046,112.546,116.542,118.792,126.289,130.285,134.785,137.287,141.283,145.783,148.285,150.535,156.538,160.534,165.034,167.536,171.532,175.033,177.283,179.533,185.536,189.532,194.032,197.533,202.033,204.535,209.035,213.535,217.531,219.781,222.778,225.028,232.525,237.025,239.527,242.029,244.531,249.031,251.533,255.529,257.779,262.279,266.275,268.777,272.773,276.274,280.774,284.275,286.777,290.278" svgx:width="0.67,0.56,0.72,0.25,0.56,0.5,0.5,0.5,0.5,0.5,0.44,0.25,0.83,0.44,0.5,0.28,0.44,0.5,0.28,0.25,0.67,0.44,0.5,0.28,0.44,0.39,0.25,0.25,0.67,0.44,0.5,0.39,0.5,0.28,0.5,0.5,0.44,0.25,0.33,0.25,0.83,0.5,0.28,0.28,0.28,0.5,0.28,0.44,0.25,0.5,0.44,0.28,0.44,0.39,0.5,0.39,0.28,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">NYU Langone Medical Center, Neurology - Multiple Sclerosis </text>
   <text y="166.988" x="62.362,68.365,72.865,79.363,83.863,87.364,91.36,95.86,99.856,104.356,107.857,110.359,114.355,118.351,120.601,126.604,131.104,134.605,138.601,140.851,146.854,150.85,155.35,157.852,161.848,165.349,167.599,169.849,175.852,179.848,185.851,188.101,193.105,197.605,201.106,205.102,207.352,209.602,215.605,220.609,222.859,225.109,231.607,236.107,238.609,241.111,245.107,249.607,251.857,256.357,258.859,263.359,265.861,269.857" svgx:width="0.67,0.5,0.72,0.5,0.39,0.44,0.5,0.44,0.5,0.39,0.28,0.44,0.44,0.25,0.67,0.5,0.39,0.44,0.25,0.67,0.44,0.5,0.28,0.44,0.39,0.25,0.25,0.67,0.44,0.67,0.25,0.56,0.5,0.39,0.44,0.25,0.25,0.67,0.56,0.25,0.25,0.72,0.5,0.28,0.28,0.44,0.5,0.25,0.5,0.28,0.5,0.28,0.44,0.39" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Comprehensive Care Center, New York, NY, United States</text>
   <text y="193.988" x="62.362,68.365,72.865,76.861,81.865,86.365,90.199,94.699,99.703,104.707,109.711,112.708" svgx:width="0.67,0.5,0.44,0.56,0.5,0.44,0.5,0.56,0.56,0.56,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Background: </text>
   <text y="193.988" x="123.472,126.469,130.969,133.219,141.733,146.233,150.229,152.731,155.233,159.229,163.729,166.231,169.732,171.982,180.496,186.994,189.496,191.998,196.498,198.748,207.262,212.266,215.263,219.763,224.263,227.26,231.256,234.757,238.258,240.76,245.26,249.256,251.506,260.02,268.021,272.521,275.023,277.525,280.027,283.024,287.524,291.52,295.516,298.018" svgx:width="0.33,0.5,0.25,0.55,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.55,0.72,0.28,0.28,0.5,0.25,0.55,0.56,0.33,0.5,0.5,0.33,0.44,0.39,0.39,0.28,0.5,0.44,0.25,0.55,0.89,0.5,0.28,0.28,0.28,0.33,0.5,0.44,0.44,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">In patients with Progressive Multifocal </text>
   <text y="204.986" x="62.362,67.861,71.857,76.357,80.857,85.357,89.353,93.853,97.849,101.845,106.345,110.845,114.841,117.343,121.843,126.343,130.339,132.841,137.341,141.841,144.091,147.142,150.643,154.639,158.635,163.135,167.635,172.135,176.131,179.128,183.628,185.878,188.929,191.431,195.931,198.181,201.232,207.73,211.726,214.228,218.224,220.726,223.228,227.224,231.724,238.726,242.722,247.222,249.472,252.523,255.52,260.524,268.525,274.024,277.021,283.519,289.018,295.021,298.018" svgx:width="0.61,0.44,0.5,0.5,0.5,0.44,0.5,0.44,0.44,0.5,0.5,0.44,0.28,0.5,0.5,0.44,0.28,0.5,0.5,0.25,0.55,0.39,0.44,0.44,0.5,0.5,0.5,0.44,0.33,0.5,0.25,0.55,0.28,0.5,0.25,0.55,0.72,0.44,0.28,0.44,0.28,0.28,0.44,0.5,0.78,0.44,0.5,0.25,0.55,0.33,0.56,0.89,0.61,0.33,0.72,0.61,0.67,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Leukoencephalopathy secondary to Natalizumab (PML-NZB) </text>
   <text y="215.984" x="62.362,64.864,71.866,78.868,83.368,87.868,91.864,94.114,95.23,98.227,102.223,106.219,110.719,115.219,118.72,121.222,123.724,126.226,130.726,133.228,135.73,140.23,144.73,146.98,148.096,150.598,155.098,158.095,160.597,164.593,171.595,178.597,182.593,185.095,189.595,192.592,197.092,199.342,200.458,203.959,208.459,212.959,217.459,220.456,224.956,231.958,235.954,238.204,239.32,242.317,245.314,251.317,254.314,259.318,262.315,264.565,265.681,270.181,274.177,277.678,279.928,281.044,285.544,289.54,293.536,298.036" svgx:width="0.28,0.78,0.78,0.5,0.5,0.44,0.25,0.55,0.33,0.44,0.44,0.5,0.5,0.39,0.28,0.28,0.28,0.5,0.28,0.28,0.5,0.5,0.25,0.55,0.28,0.5,0.33,0.28,0.44,0.78,0.78,0.44,0.28,0.5,0.33,0.5,0.25,0.55,0.39,0.5,0.5,0.5,0.33,0.5,0.78,0.44,0.25,0.55,0.33,0.33,0.67,0.33,0.56,0.33,0.25,0.55,0.5,0.44,0.39,0.25,0.55,0.5,0.44,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">immune reconstitution inflammatory syndrome (IRIS) has been </text>
   <text y="226.982" x="62.362,65.359,69.355,73.855,77.851,80.848,85.348,89.344,93.844,96.094,97.777,101.773,105.274,107.524,109.207,113.707,117.703,121.699,124.696,127.198,131.698,133.948,135.631,140.131,144.631,147.133,151.633,155.629,158.626,162.127,166.123,168.625,170.875,173.125,174.808,180.811,185.311,188.308,191.305,195.301,199.801,202.303,204.805,209.305,211.555,213.238,215.74,220.24,224.236,227.233,231.229,233.479,235.162,239.158,242.155,246.151,248.401,250.084,254.584,259.084,261.334,263.017,267.013,271.513,274.015,278.515,282.511,287.011,291.007,295.003" svgx:width="0.33,0.44,0.5,0.44,0.33,0.5,0.44,0.5,0.25,0.55,0.44,0.39,0.25,0.55,0.5,0.44,0.44,0.33,0.28,0.5,0.25,0.55,0.5,0.5,0.28,0.5,0.44,0.33,0.39,0.44,0.28,0.25,0.25,0.55,0.67,0.5,0.33,0.33,0.44,0.5,0.28,0.28,0.5,0.25,0.55,0.28,0.5,0.44,0.33,0.44,0.25,0.55,0.44,0.33,0.44,0.25,0.55,0.5,0.5,0.25,0.55,0.44,0.5,0.28,0.5,0.44,0.5,0.44,0.44,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">regarded as nearly universal. Currently there are no evidence-</text>
   <text y="237.98" x="62.362,66.862,70.858,74.359,78.355,82.855,85.105,86.023,88.525,91.522,95.518,99.514,102.016,109.018,113.014,117.514,120.016,123.517,125.767,126.685,129.682,134.182,137.179,139.429,140.347,143.344,149.347,152.344,157.348,159.598,161.848,162.766,169.264,171.766,176.266,180.262,184.762,188.758,193.258,196.255,198.757,201.259,205.255,209.755,212.257,216.757,220.258,222.508,223.426,227.422,230.419,234.415,236.665,237.583,241.579,246.079,253.081,260.083,264.583,269.083,271.585,276.085,278.335,279.253,283.753,287.254,291.25,295.75,298.0" svgx:width="0.5,0.44,0.39,0.44,0.5,0.25,0.55,0.28,0.33,0.44,0.44,0.28,0.78,0.44,0.5,0.28,0.39,0.25,0.55,0.33,0.5,0.33,0.25,0.55,0.33,0.67,0.33,0.56,0.25,0.25,0.55,0.72,0.28,0.5,0.44,0.5,0.44,0.5,0.33,0.28,0.28,0.44,0.5,0.28,0.5,0.39,0.25,0.55,0.44,0.33,0.44,0.25,0.55,0.44,0.5,0.78,0.78,0.5,0.5,0.28,0.5,0.25,0.55,0.5,0.39,0.44,0.5,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">based treatments for IRIS. Glucocorticoids are commonly used, </text>
   <text y="248.978" x="62.362,66.862,71.362,73.864,76.114,77.491,79.993,84.493,86.995,90.496,92.746,94.123,101.125,105.121,109.621,111.871,113.248,115.75,120.25,124.75,127.252,131.752,134.254,136.756,139.006,140.383,143.884,149.887,152.137,153.514,158.014,160.516,163.513,168.013,171.514,173.764,175.141,179.137,181.639,185.635,189.631,192.628,196.624,201.124,205.12,209.116,211.366,212.743,216.739,221.239,225.739,227.989,229.366,235.864,240.364,243.361,246.862,250.858,255.358,257.608,258.985,263.485,267.985,272.485,276.481,279.478,281.98,286.48,288.982,293.482,297.982" svgx:width="0.5,0.5,0.28,0.25,0.55,0.28,0.5,0.28,0.39,0.25,0.55,0.78,0.44,0.5,0.25,0.55,0.28,0.5,0.5,0.28,0.5,0.28,0.28,0.25,0.55,0.39,0.67,0.25,0.55,0.5,0.28,0.33,0.5,0.39,0.25,0.55,0.44,0.28,0.44,0.44,0.33,0.44,0.5,0.44,0.44,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.72,0.5,0.33,0.39,0.44,0.5,0.25,0.55,0.5,0.5,0.5,0.44,0.33,0.28,0.5,0.28,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">but this may inhibit JC virus clearance and worsen underlying </text>
   <text y="259.976" x="62.362,67.366,75.367,80.866,83.116,85.447,91.45,95.95,99.946,106.948,111.448,115.948,118.45,122.95,126.946,129.277,132.274,136.27,140.266,144.262,148.762,151.264,155.764,158.761,161.092,165.592,168.589,173.089,177.589,181.09,183.592,186.094,188.596,193.096,197.092,199.423,202.42,208.423,214.426,220.429,224.929,230.005,233.002,235.171,240.508,242.839,246.835,250.831,253.333,255.835,259.336,261.667,266.167,270.163,274.663,278.659,280.99,285.49,289.486,293.482,297.982" svgx:width="0.56,0.89,0.61,0.25,0.25,0.67,0.5,0.44,0.78,0.5,0.5,0.28,0.5,0.44,0.25,0.33,0.44,0.44,0.44,0.5,0.28,0.5,0.33,0.25,0.5,0.33,0.5,0.5,0.39,0.28,0.28,0.28,0.5,0.44,0.25,0.33,0.67,0.67,0.67,0.5,0.56,0.33,0.25,0.61,0.25,0.44,0.44,0.28,0.28,0.39,0.25,0.5,0.44,0.5,0.44,0.25,0.5,0.44,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">PML. Chemokine receptor 5-positive (CCR5+) T cells have been </text>
   <text y="270.974" x="62.362,64.864,69.364,73.864,76.366,79.363,83.359,87.355,89.857,92.359,96.859,99.109,102.484,104.986,111.988,116.488,118.99,121.492,125.488,129.484,131.986,135.982,140.482,142.732,146.107,148.609,153.109,155.359,158.734,161.731,167.734,170.731,175.735,177.985,181.36,185.86,189.856,192.358,196.858,201.358,205.858,210.358,214.858,218.359,220.861,225.361,227.863,232.363,236.863,240.778,243.028,245.278,248.653,256.654,260.65,263.647,267.643,272.143,274.645,277.642,282.142,286.138,288.388,290.638,294.013,298.009" svgx:width="0.28,0.5,0.5,0.28,0.33,0.44,0.44,0.28,0.28,0.5,0.25,0.55,0.28,0.78,0.5,0.28,0.28,0.44,0.44,0.28,0.44,0.5,0.25,0.55,0.28,0.5,0.25,0.55,0.33,0.67,0.33,0.56,0.25,0.55,0.5,0.44,0.28,0.5,0.5,0.5,0.5,0.5,0.39,0.28,0.5,0.28,0.5,0.5,0.5,0.25,0.25,0.55,0.89,0.44,0.33,0.44,0.5,0.28,0.33,0.5,0.44,0.25,0.25,0.55,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">indirectly implicated in IRIS pathophysiology. Maraviroc, a </text>
   <text y="281.972" x="62.362,68.365,74.368,80.371,84.871,87.643,91.639,96.139,98.641,102.637,107.137,111.637,116.137,118.639,122.14,124.642,127.414,131.41,135.91,140.41,143.407,147.907,152.407,156.403,160.903,163.675,166.672,171.172,174.169,176.941,179.443,183.943,187.939,190.711,193.213,196.21,200.206,204.202,206.704,213.706,217.702,222.202,224.704,227.476,231.976,234.973,237.745,242.245,246.745,253.747,257.743,262.243,265.015,267.517,274.519,281.521,286.021,290.521,295.021" svgx:width="0.67,0.67,0.67,0.5,0.25,0.44,0.5,0.28,0.44,0.5,0.5,0.5,0.28,0.39,0.28,0.25,0.44,0.5,0.5,0.33,0.5,0.5,0.44,0.5,0.25,0.33,0.5,0.33,0.25,0.28,0.5,0.44,0.25,0.28,0.33,0.44,0.44,0.28,0.78,0.44,0.5,0.28,0.25,0.5,0.33,0.25,0.5,0.5,0.78,0.44,0.5,0.25,0.28,0.78,0.78,0.5,0.5,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">CCR5 antagonist approved for the treatment of human immuno-</text>
   <text y="292.97" x="62.362,66.862,70.858,73.855,76.357,80.353,82.855,86.851,91.351,95.347,99.847,102.097,102.934,107.434,109.936,112.933,117.433,120.934,123.184,124.021,127.018,133.516,136.513,143.011,146.008,148.258,149.095,151.597,156.097,159.094,163.09,167.086,169.588,172.09,176.59,181.09,183.34,185.59,186.427,193.429,197.425,201.925,204.175,205.012,209.512,212.014,216.514,221.014,223.516,225.766,226.603,229.6,235.603,238.6,243.604,245.854,246.691,249.193,253.693,255.943,256.78,261.784,269.785,275.284,278.281,284.779,290.278,295.777,298.027" svgx:width="0.5,0.44,0.33,0.28,0.44,0.28,0.44,0.5,0.44,0.5,0.25,0.55,0.5,0.28,0.33,0.5,0.39,0.25,0.55,0.33,0.72,0.33,0.72,0.33,0.25,0.55,0.28,0.5,0.33,0.44,0.44,0.28,0.28,0.5,0.5,0.25,0.25,0.55,0.78,0.44,0.5,0.25,0.55,0.5,0.28,0.5,0.5,0.28,0.25,0.55,0.33,0.67,0.33,0.56,0.25,0.55,0.28,0.5,0.25,0.55,0.56,0.89,0.61,0.33,0.72,0.61,0.61,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">deficiency virus (HIV) infection, may blunt IRIS in PML-NTZ. </text>
   <text y="303.968" x="62.362,67.231,71.731,74.233,78.733,83.233,86.23,88.741,93.241,97.741,102.241,108.739,111.241,115.237,119.737,124.237,128.233,130.483,132.985,135.487,139.987,143.983,146.98,150.976,153.478,155.98,159.481,161.983,166.483,170.983,173.485,177.985,180.487,184.483,186.985,190.486,192.988,197.488,201.988,204.49,208.486,210.988,215.488,219.988,224.488,226.99,229.492,232.993,237.493,241.489,245.989,248.5,252.496,256.492,259.993,263.989,266.491,269.488,273.484,277.984,282.484,285.481,287.983,290.485,294.985,297.982" svgx:width="0.61,0.5,0.25,0.5,0.5,0.33,0.25,0.5,0.5,0.5,0.72,0.28,0.44,0.5,0.5,0.44,0.25,0.25,0.28,0.5,0.44,0.33,0.44,0.25,0.28,0.39,0.25,0.5,0.5,0.28,0.5,0.25,0.44,0.25,0.39,0.28,0.5,0.5,0.28,0.44,0.25,0.5,0.5,0.5,0.28,0.28,0.39,0.5,0.44,0.5,0.25,0.44,0.44,0.39,0.44,0.25,0.33,0.44,0.5,0.5,0.33,0.28,0.25,0.5,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">To our knowledge, there is only a single published case report of </text>
   <text y="314.966" x="62.362,66.358,69.193,72.19,76.186,80.182,82.684,85.186,89.686,93.682,95.932,100.432,103.933,107.929,110.179,114.679,117.676,119.926,127.927,131.923,134.92,138.916,143.416,145.918,148.915,153.415,157.411,159.661,162.163,166.663,168.913,171.415,175.915,178.417,181.918,184.168,188.164,190.666,193.168,197.668,200.17,204.166,208.162,210.664,212.914,216.415,220.411,222.913,225.415,227.917,232.417,236.917" svgx:width="0.44,0.33,0.33,0.44,0.44,0.28,0.28,0.5,0.44,0.25,0.5,0.39,0.44,0.25,0.5,0.33,0.25,0.89,0.44,0.33,0.44,0.5,0.28,0.33,0.5,0.44,0.25,0.28,0.5,0.25,0.28,0.5,0.28,0.39,0.25,0.44,0.28,0.28,0.5,0.28,0.44,0.44,0.28,0.25,0.39,0.44,0.28,0.28,0.28,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">effective use of Maraviroc in this clinical setting.</text>
   <text y="325.964" x="62.362,69.364,74.368,77.365,81.361,85.357,88.354,90.856,95.356,99.352,102.853,105.85" svgx:width="0.78,0.56,0.33,0.44,0.44,0.33,0.28,0.5,0.44,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Objectives: </text>
   <text y="325.964" x="107.956,112.825,117.325,119.431,122.428,126.424,130.924,135.424,138.421,140.923,143.029,147.529,152.029,154.135,156.637,163.135,167.635,169.741,173.737,177.733,181.234,185.23,188.731,190.837,195.337,198.334,200.44,208.441,212.437,215.434,219.43,223.93,226.432,229.429,233.929,237.925,240.922,243.424,246.421,250.417,254.413,256.915,260.911,265.411,267.517,272.017,274.519,278.02,281.521,285.517,292.519,295.021" svgx:width="0.61,0.5,0.25,0.33,0.44,0.5,0.5,0.33,0.28,0.25,0.5,0.5,0.25,0.28,0.72,0.5,0.25,0.44,0.44,0.39,0.44,0.39,0.25,0.5,0.33,0.25,0.89,0.44,0.33,0.44,0.5,0.28,0.33,0.5,0.44,0.33,0.28,0.33,0.44,0.44,0.28,0.44,0.5,0.25,0.5,0.28,0.39,0.39,0.44,0.78,0.28,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">To report on two cases of Maraviroc-treated dissemi-</text>
   <text y="336.962" x="62.362,66.862,70.858,73.36,77.356,81.856,84.277,89.281,97.282,102.781,105.778,112.276,117.775,123.274,125.695,128.692,131.689,136.189,143.191,145.612,152.11,158.608,165.106,167.527,175.528,180.532,182.953,188.956,192.952,197.452,199.954,203.95,206.947,209.368,211.87,216.37,218.791,225.289,229.789,232.291,236.287,240.787,243.208,247.708,252.208,254.629,258.625,261.127,263.629,268.129,270.631,274.627,278.623,281.125,283.627,288.127,290.548,295.048,298.045" svgx:width="0.5,0.44,0.28,0.44,0.5,0.25,0.56,0.89,0.61,0.33,0.72,0.61,0.61,0.25,0.33,0.33,0.5,0.78,0.25,0.72,0.72,0.72,0.25,0.89,0.56,0.25,0.67,0.44,0.5,0.28,0.44,0.33,0.25,0.28,0.5,0.25,0.72,0.5,0.28,0.44,0.5,0.25,0.5,0.5,0.25,0.44,0.28,0.28,0.5,0.28,0.44,0.44,0.28,0.28,0.5,0.25,0.5,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">nated PML-NTZ from NYU MS Center in which no clinically or </text>
   <text y="347.96" x="62.362,65.359,69.355,73.855,76.357,80.857,83.359,87.859,92.359,94.861,98.857,102.853,105.355,107.857,112.357,114.571,118.072,120.574,125.074,129.574,132.076,135.073,137.575,141.571,145.567,150.067,152.569,154.774,157.771,163.774,166.771,171.775,173.989,180.487,184.483,187.984,190.198,194.698,199.198,202.699,206.695,209.692,214.192,218.188,222.688,224.902,229.402,233.902,237.898,240.895,243.109,247.609,250.606,255.106,259.606,261.82,268.822,273.322,277.822,280.324,284.824,288.325,290.539,295.039,298.036" svgx:width="0.33,0.44,0.5,0.28,0.5,0.28,0.5,0.5,0.28,0.44,0.44,0.28,0.28,0.5,0.25,0.39,0.28,0.5,0.5,0.28,0.33,0.28,0.44,0.44,0.5,0.28,0.25,0.33,0.67,0.33,0.56,0.25,0.72,0.44,0.39,0.25,0.5,0.5,0.39,0.44,0.33,0.5,0.44,0.5,0.25,0.5,0.5,0.44,0.33,0.25,0.5,0.33,0.5,0.5,0.25,0.78,0.5,0.5,0.28,0.5,0.39,0.25,0.5,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">radiologically significant IRIS was observed over 3-15 months of </text>
   <text y="358.958" x="62.362,65.359,69.859,72.361,74.863,79.363,85.861,88.111,92.611,97.111" svgx:width="0.33,0.5,0.28,0.28,0.5,0.72,0.25,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">follow up.</text>
   <text y="369.956" x="62.362,70.858,74.854,77.851,82.855,87.355,92.359,95.86,98.857" svgx:width="0.94,0.44,0.33,0.56,0.5,0.56,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Methods: </text>
   <text y="369.956" x="101.107,107.11,111.106,114.607,118.603,120.853,124.354,128.35,131.347,133.849,137.845,141.346" svgx:width="0.67,0.44,0.39,0.44,0.25,0.39,0.44,0.33,0.28,0.44,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Case series.</text>
   <text y="380.954" x="62.362,68.86,72.856,76.357,81.361,83.863,86.86,90.361,93.358" svgx:width="0.72,0.44,0.39,0.56,0.28,0.33,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Results: </text>
   <text y="380.954" x="96.778,102.277,106.777,110.773,113.023,114.193,117.19,119.692,122.689,126.19,128.692,130.942,132.112,136.612,140.608,143.11,145.612,149.608,154.108,156.61,158.86,160.03,162.532,166.033,168.283,169.453,173.953,178.453,180.703,181.873,186.373,190.369,194.365,197.362,199.612,200.782,205.282,207.784,212.284,214.534,215.704,222.202,226.702,233.704,237.7,242.2,244.45,245.62,252.118,254.62,257.122,261.622,263.872,265.042,268.039,272.035,274.537,278.533,283.033,286.534,289.036,293.536,298.036" svgx:width="0.61,0.5,0.44,0.25,0.55,0.33,0.28,0.33,0.39,0.28,0.25,0.55,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.25,0.55,0.28,0.39,0.25,0.55,0.5,0.5,0.25,0.55,0.5,0.44,0.44,0.33,0.25,0.55,0.5,0.28,0.5,0.25,0.55,0.72,0.5,0.78,0.44,0.5,0.25,0.55,0.72,0.28,0.28,0.5,0.25,0.55,0.33,0.44,0.28,0.44,0.5,0.39,0.28,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">The first patient is 49 year old woman with relapsing </text>
   <text y="391.952" x="62.362,65.359,69.355,76.357,78.859,81.361,83.863,86.365,90.865,95.365,97.615,99.442,106.444,110.944,113.446,115.948,118.45,122.95,125.452,129.448,131.698,133.525,137.026,141.022,143.524,147.52,150.517,155.017,158.518,161.02,164.521,166.771,168.598,171.595,177.598,183.601,191.602,196.606,199.603,201.853,203.68,208.18,212.68,214.93,216.757,223.255,228.754,234.757,237.007,238.834,241.831,246.331,249.328,251.578,253.405,257.905,260.155,261.982,266.482,270.478,274.474,277.471,280.972,283.222,285.049,289.045,293.545,298.045" svgx:width="0.33,0.44,0.78,0.28,0.28,0.28,0.28,0.5,0.5,0.25,0.55,0.78,0.5,0.28,0.28,0.28,0.5,0.28,0.44,0.25,0.55,0.39,0.44,0.28,0.44,0.33,0.5,0.39,0.28,0.39,0.25,0.55,0.33,0.67,0.67,0.89,0.56,0.33,0.25,0.55,0.5,0.5,0.25,0.55,0.72,0.61,0.67,0.25,0.55,0.33,0.5,0.33,0.25,0.55,0.5,0.25,0.55,0.5,0.44,0.44,0.33,0.39,0.25,0.55,0.44,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">remitting multiple sclerosis (RRMS) on NZB for 3 years and </text>
   <text y="402.95" x="62.362,66.862,73.864,78.364,82.864,85.366,89.866,93.367,95.617,96.688,103.186,107.686,112.186,114.436,115.507,120.007,123.004,127.0,130.501,134.497,138.997,141.499,145.495,149.995,152.245,153.307,156.304,160.804,163.801,166.051,167.122,171.118,173.368,174.43,177.931,181.927,185.923,190.423,194.923,199.423,201.673,202.744,207.244,211.744,214.246,218.746,221.248,225.748,230.248,232.498,233.569,240.067,242.569,245.071,249.571,251.821,252.883,257.383,259.633,260.704,267.706,272.206,276.706,279.208,283.708,287.209,289.459,290.53,295.03,298.027" svgx:width="0.5,0.78,0.5,0.5,0.28,0.5,0.39,0.25,0.55,0.72,0.5,0.5,0.25,0.55,0.5,0.33,0.44,0.39,0.44,0.5,0.28,0.44,0.5,0.25,0.55,0.33,0.5,0.33,0.25,0.55,0.44,0.25,0.55,0.39,0.44,0.44,0.5,0.5,0.5,0.25,0.55,0.5,0.5,0.28,0.5,0.28,0.5,0.5,0.25,0.55,0.72,0.28,0.28,0.5,0.25,0.55,0.5,0.25,0.55,0.78,0.5,0.5,0.28,0.5,0.39,0.25,0.55,0.5,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">6months who presented for a second opinion with 3 months of </text>
   <text y="413.948" x="62.362,68.86,73.36,76.357,79.858,83.854,88.354,90.856,95.356,99.856,102.106,104.491,108.991,113.491,120.493,124.993,129.493,133.489,136.99,140.491,142.741,144.991,147.376,151.372,153.874,157.87,162.37,164.872,168.868,171.118,173.368,175.753,179.749,184.249,188.749,190.999,193.384,197.884,202.384,205.885,209.881,212.878,215.38,219.88,222.877,225.379,229.375,231.625,233.875,236.26,242.263,245.26,249.256,251.758,256.258,258.508,260.893,268.894,274.897,277.894,280.144,282.529,286.03,290.53,295.03" svgx:width="0.72,0.5,0.33,0.39,0.44,0.5,0.28,0.5,0.5,0.25,0.55,0.5,0.5,0.78,0.5,0.5,0.44,0.39,0.39,0.25,0.25,0.55,0.44,0.28,0.44,0.5,0.28,0.44,0.25,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.5,0.5,0.39,0.44,0.33,0.28,0.5,0.33,0.28,0.44,0.25,0.25,0.55,0.67,0.33,0.44,0.28,0.5,0.25,0.55,0.89,0.67,0.33,0.25,0.55,0.39,0.5,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">worsening numbness, ataxia, and dysarthria. Brain MRI sug-</text>
   <text y="424.946" x="62.362,66.862,70.858,74.359,76.861,80.857,85.357,87.805,94.303,96.805,101.305,105.301,107.749,110.746,114.247,118.747,121.744,125.74,129.736,134.236,136.684,141.688,149.689,154.855,157.303,161.299,165.799,170.299,172.747,176.248,180.748,183.25,187.75,191.746,194.248,196.696,199.693,202.195,206.695,209.197,213.697,216.145,220.141,224.641,228.637,231.139,235.639,239.14,241.642,245.143,247.591,251.587,256.087,260.587,263.584,266.086,269.083,276.085,280.081,284.581,287.029,289.531,294.031,298.027" svgx:width="0.5,0.44,0.39,0.28,0.44,0.5,0.25,0.72,0.28,0.5,0.44,0.25,0.33,0.39,0.5,0.33,0.44,0.44,0.5,0.25,0.56,0.89,0.61,0.25,0.44,0.5,0.5,0.25,0.39,0.5,0.28,0.5,0.44,0.28,0.25,0.33,0.28,0.5,0.28,0.5,0.25,0.44,0.5,0.44,0.28,0.5,0.39,0.28,0.39,0.25,0.44,0.5,0.5,0.33,0.28,0.33,0.78,0.44,0.5,0.25,0.28,0.5,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">gested wide -spread PML and spinal fluid analysis confirmed the </text>
   <text y="435.944" x="62.362,66.862,69.364,73.36,77.86,82.36,86.86,90.361,92.863,96.364,98.614,100.639,107.137,109.639,112.141,116.641,118.666,123.166,127.666,132.166,134.191,137.692,143.695,150.031,152.056,156.052,160.552,165.052,167.554,171.55,175.051,177.553,184.555,189.721,191.746,196.246,200.242,202.744,206.74,210.736,213.238,217.234,221.734,223.759,226.756,231.76,236.26,240.256,244.756,248.257,250.282,256.78,259.282,263.278,267.778,272.278,276.778,280.279,282.781,285.283,289.279,292.78,295.777,298.027" svgx:width="0.5,0.28,0.44,0.5,0.5,0.5,0.39,0.28,0.39,0.25,0.25,0.72,0.28,0.28,0.5,0.25,0.5,0.5,0.5,0.25,0.39,0.67,0.72,0.25,0.44,0.5,0.5,0.28,0.44,0.39,0.28,0.78,0.61,0.25,0.5,0.44,0.28,0.44,0.44,0.28,0.44,0.5,0.25,0.33,0.56,0.5,0.44,0.5,0.39,0.25,0.72,0.28,0.44,0.5,0.5,0.5,0.39,0.28,0.28,0.44,0.39,0.33,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">diagnosis, with 390 JCV copies/mL detected (Focus Diagnostics). </text>
   <text y="446.942" x="62.362,70.363,74.359,77.356,81.352,85.852,88.354,91.351,95.851,99.847,102.556,107.056,111.556,116.056,123.058,127.558,130.276,132.778,139.276,141.778,145.774,149.77,152.479,156.475,159.184,163.684,167.68,172.18,174.889,181.387,185.383,188.884,191.593,194.095,198.595,201.097,203.599,206.101,210.097,212.599,216.595,221.095,223.804,227.8,230.797,233.299,237.295,240.292,243.001,247.501,250.003,253.999,257.5,264.502,268.498,272.998,277.498,281.494,284.491,288.487,291.988,294.49,297.991" svgx:width="0.89,0.44,0.33,0.44,0.5,0.28,0.33,0.5,0.44,0.25,0.5,0.5,0.5,0.78,0.5,0.25,0.28,0.72,0.28,0.44,0.44,0.25,0.44,0.25,0.5,0.44,0.5,0.25,0.72,0.44,0.39,0.25,0.28,0.5,0.28,0.28,0.28,0.44,0.28,0.44,0.5,0.25,0.44,0.33,0.28,0.44,0.33,0.25,0.5,0.28,0.44,0.39,0.78,0.44,0.5,0.5,0.44,0.33,0.44,0.39,0.28,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Maraviroc 300mg twice a day was initiated after plasmapheresis </text>
   <text y="457.94" x="62.362,65.359,70.363,75.862,81.361,87.859,90.856,93.106,95.356,97.633,102.637,106.633,109.135,111.637,115.633,120.133,122.635,124.885,127.162,130.159,134.155,141.157,145.153,147.655,152.155,156.151,160.651,162.901,165.178,168.175,171.172,175.168,179.164,181.414,183.691,188.191,191.188,193.438,195.715,199.711,202.213,204.715,209.215,211.717,215.713,219.709,222.211,224.713,229.213,231.463,233.74,237.241,239.743,244.243,248.743,251.245,254.242,256.744,260.74,264.736,269.236,271.738,274.24,276.49,278.767,281.764,287.767,290.764,295.768,298.018" svgx:width="0.33,0.56,0.61,0.61,0.72,0.33,0.25,0.25,0.55,0.56,0.44,0.28,0.28,0.44,0.5,0.28,0.25,0.55,0.33,0.44,0.78,0.44,0.28,0.5,0.44,0.5,0.25,0.55,0.33,0.33,0.44,0.44,0.25,0.55,0.5,0.33,0.25,0.55,0.44,0.28,0.28,0.5,0.28,0.44,0.44,0.28,0.28,0.5,0.25,0.55,0.39,0.28,0.5,0.5,0.28,0.33,0.28,0.44,0.44,0.5,0.28,0.28,0.25,0.55,0.33,0.67,0.33,0.56,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">(PLEX). Patient remained free of clinically significantl IRIS. </text>
   <text y="468.938" x="62.362,67.366,71.362,73.864,76.366,80.362,84.862,87.364,89.866,93.367,95.617,97.444,101.44,103.942,106.444,110.944,113.446,117.442,121.438,123.94,126.19,128.017,131.518,134.02,138.016,140.518,145.018,148.519,150.769,152.596,156.592,161.092,165.592,167.842,169.669,177.67,183.673,186.67,188.92,190.747,194.248,196.75,200.746,205.246,207.748,210.25,212.752,216.748,220.744,225.244,227.494,229.321,233.821,238.321,242.317,245.314,247.564,249.391,253.891,256.14099999999996,257.968,264.97,269.47,273.97,276.472,280.972,283.222,285.049,289.045,293.545,298.045" svgx:width="0.56,0.44,0.28,0.28,0.44,0.5,0.28,0.33,0.39,0.25,0.55,0.44,0.28,0.28,0.5,0.28,0.44,0.44,0.28,0.25,0.55,0.39,0.28,0.44,0.28,0.5,0.39,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.89,0.67,0.33,0.25,0.55,0.39,0.28,0.44,0.5,0.28,0.28,0.28,0.44,0.44,0.5,0.25,0.55,0.5,0.5,0.44,0.33,0.25,0.55,0.5,0.25,0.55,0.78,0.5,0.5,0.28,0.5,0.25,0.55,0.44,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Patient’s clinical status and MRI stabilized over 6 month and </text>
   <text y="479.936" x="62.362,70.363,74.359,77.356,81.352,85.852,88.354,91.351,95.851,99.847,102.097,103.546,110.044,114.04,117.541,119.791,121.24,123.742,127.738,132.238,136.234,139.231,143.227,147.727,149.977,152.227,153.676,158.68,162.676,165.178,167.68,171.676,176.176,178.678,180.928,182.377,188.875,192.871,196.372,198.622,200.071,204.571,207.073,210.574,214.57,219.07,223.066,225.901,230.401,234.397,238.897,241.147,242.596,247.096,251.596,258.598,262.594,264.844,266.293,268.795,273.295,275.545,276.994,280.495,282.997,286.993,291.493,293.995,297.991" svgx:width="0.89,0.44,0.33,0.44,0.5,0.28,0.33,0.5,0.44,0.25,0.55,0.72,0.44,0.39,0.25,0.55,0.28,0.44,0.5,0.44,0.33,0.44,0.5,0.25,0.25,0.55,0.56,0.44,0.28,0.28,0.44,0.5,0.28,0.25,0.55,0.72,0.44,0.39,0.25,0.55,0.5,0.28,0.39,0.44,0.5,0.44,0.33,0.5,0.44,0.5,0.25,0.55,0.5,0.5,0.78,0.44,0.25,0.55,0.28,0.5,0.25,0.55,0.39,0.28,0.44,0.5,0.28,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Maraviroc was tapered. Patient was discharged home in stable </text>
   <text y="490.934" x="62.362,66.358,70.858,75.358,79.858,82.36,84.862,87.364,91.864,96.364,98.866,101.287,105.787,109.783,112.78,115.201,120.7,127.198,132.202,137.206,139.627,142.129,145.63,148.051,152.551,154.801,159.301,161.551,163.972,168.976,172.972,176.968,181.468,185.968,190.468,192.889,197.389,201.385,203.887,206.389,210.385,214.885,217.387,219.808,222.31,225.811,228.232,232.732,237.232,239.653,244.153,248.149,252.145,255.142,257.563,262.063,264.565,269.065,271.486,277.984,282.484,289.486,293.482,297.982" svgx:width="0.44,0.5,0.5,0.5,0.28,0.28,0.28,0.5,0.5,0.28,0.25,0.5,0.44,0.33,0.25,0.61,0.72,0.56,0.56,0.25,0.28,0.39,0.25,0.5,0.25,0.5,0.25,0.25,0.56,0.44,0.44,0.5,0.5,0.5,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.25,0.28,0.39,0.25,0.5,0.5,0.25,0.5,0.44,0.44,0.33,0.25,0.5,0.28,0.5,0.25,0.72,0.5,0.78,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">condition; her EDSS is 6.5. Second patient is 47 year old woman </text>
   <text y="501.932" x="62.362,68.86,71.362,73.864,78.364,80.614,81.739,87.742,93.745,101.746,106.75,109.0,110.125,114.625,119.125,121.375,122.5,128.998,134.497,140.5,142.75,143.875,146.872,151.372,154.369,156.619,157.744,162.244,164.494,165.619,170.119,174.115,178.111,181.108,184.609,186.859,187.984,191.98,196.48,200.98,203.23,204.355,208.855,211.105,212.23,219.232,223.732,228.232,230.734,235.234,238.735,240.985,242.11,248.608,253.108,257.608,259.858,260.983,265.483,269.479,273.979,277.975,280.477,284.977,289.477,293.473,297.973" svgx:width="0.72,0.28,0.28,0.5,0.25,0.55,0.67,0.67,0.89,0.56,0.25,0.55,0.5,0.5,0.25,0.55,0.72,0.61,0.67,0.25,0.55,0.33,0.5,0.33,0.25,0.55,0.5,0.25,0.55,0.5,0.44,0.44,0.33,0.39,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.5,0.25,0.55,0.78,0.5,0.5,0.28,0.5,0.39,0.25,0.55,0.72,0.5,0.5,0.25,0.55,0.5,0.44,0.5,0.44,0.28,0.5,0.5,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">with RRMS on NZB for 6 years and 9 months who developed </text>
   <text y="512.93" x="62.362,66.862,69.859,74.359,78.859,81.856,85.852,89.353,92.854,95.356,99.856,103.852,106.417,109.414,111.916,116.416,120.916,123.418,125.983,128.485,132.985,139.483,143.479,146.476,149.041,153.037,157.537,160.039,163.036,167.032,174.034,176.536,179.038,183.538,186.103,192.601,196.597,200.593,205.093,209.593,213.589,217.09,220.591,222.841,225.406,231.409,234.406,238.402,240.904,245.404,247.969,255.97,261.973,264.97,267.535,270.532,274.528,279.028,283.024,287.02,289.522,293.518,298.018" svgx:width="0.5,0.33,0.5,0.5,0.33,0.44,0.39,0.39,0.28,0.5,0.44,0.25,0.33,0.28,0.5,0.5,0.28,0.25,0.28,0.5,0.72,0.44,0.33,0.25,0.44,0.5,0.28,0.33,0.44,0.78,0.28,0.28,0.5,0.25,0.72,0.44,0.44,0.5,0.5,0.44,0.39,0.39,0.25,0.25,0.67,0.33,0.44,0.28,0.5,0.25,0.89,0.67,0.33,0.25,0.33,0.44,0.5,0.44,0.44,0.28,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">progressive right lower extremity weakness. Brain MRI revealed </text>
   <text y="523.928" x="62.362,66.358,68.932,73.432,77.428,83.926,86.338,91.837,96.337,98.911,101.413,105.409,108.91,111.412,115.912,120.412,122.986,125.488,129.988,132.562,135.064,139.564,143.56,146.125,148.627,152.623,155.62,158.122,160.696,167.698,172.198,174.7,179.2,182.197,184.771,188.767,193.267,196.264,198.766,202.762,207.262,209.827,213.823,218.323,222.823,225.397,228.898,233.398,235.9,240.4,244.396,246.898,249.463,252.46,254.962,259.462,261.964,266.464,269.038,273.034,277.534,281.53,284.032,288.532,292.033,294.535,298.036" svgx:width="0.44,0.25,0.5,0.44,0.72,0.25,0.61,0.5,0.25,0.28,0.44,0.39,0.28,0.5,0.5,0.25,0.28,0.5,0.25,0.28,0.5,0.44,0.25,0.28,0.44,0.33,0.28,0.25,0.78,0.5,0.28,0.5,0.33,0.25,0.44,0.5,0.33,0.28,0.44,0.5,0.25,0.44,0.5,0.5,0.25,0.39,0.5,0.28,0.5,0.44,0.28,0.25,0.33,0.28,0.5,0.28,0.5,0.25,0.44,0.5,0.44,0.28,0.5,0.39,0.28,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">a new T2 lesion in the left motor cortex and spinal fluid analysis </text>
   <text y="534.926" x="62.362,66.358,70.858,75.358,78.355,80.857,83.854,90.856,94.852,99.352,101.602,102.34,104.842,109.342,113.338,115.588,116.326,120.826,123.328,127.324,131.824,136.324,140.824,144.325,146.827,150.328,152.578,154.828,155.566,162.064,164.566,167.068,171.568,173.818,174.556,179.056,183.556,185.806,186.544,190.045,196.048,202.384,204.634,205.372,209.368,213.868,218.368,220.87,224.866,228.367,230.869,237.871,243.037,245.287,246.025,250.525,254.521,257.023,261.019,265.015,267.517,271.513,276.013,278.263,279.001,281.998,288.496,291.493,297.991" svgx:width="0.44,0.5,0.5,0.33,0.28,0.33,0.78,0.44,0.5,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.5,0.28,0.44,0.5,0.5,0.5,0.39,0.28,0.39,0.25,0.25,0.55,0.72,0.28,0.28,0.5,0.25,0.55,0.5,0.5,0.25,0.55,0.39,0.67,0.72,0.25,0.55,0.44,0.5,0.5,0.28,0.44,0.39,0.28,0.78,0.61,0.25,0.55,0.5,0.44,0.28,0.44,0.44,0.28,0.44,0.5,0.25,0.55,0.33,0.72,0.33,0.72,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">confirmed the diagnosis, with 18 JCV copies/mL detected (NIH </text>
   <text y="545.924" x="62.362,64.864,68.86,73.36,77.86,80.857,84.853,87.355,91.855,94.852,99.352,102.349,104.599,106.849,107.767,115.768,119.764,122.761,126.757,131.257,133.759,136.756,141.256,145.252,147.502,148.42,154.918,158.914,162.415,164.665,165.583,168.085,172.585,175.087,177.589,180.091,184.087,186.589,190.585,195.085,197.335,198.253,202.249,205.246,207.748,211.744,214.741,216.991,217.909,222.913,228.412,233.911,240.409,242.659,244.909,245.827,252.325,256.825,259.075,259.993,263.494,265.996,270.496,274.996,277.498,280.495,282.997,286.993,290.989,295.489,297.991" svgx:width="0.28,0.44,0.5,0.5,0.33,0.44,0.28,0.5,0.33,0.5,0.33,0.25,0.25,0.55,0.89,0.44,0.33,0.44,0.5,0.28,0.33,0.5,0.44,0.25,0.55,0.72,0.44,0.39,0.25,0.55,0.28,0.5,0.28,0.28,0.28,0.44,0.28,0.44,0.5,0.25,0.55,0.44,0.33,0.28,0.44,0.33,0.25,0.55,0.56,0.61,0.61,0.72,0.25,0.25,0.55,0.72,0.5,0.25,0.55,0.39,0.28,0.5,0.5,0.28,0.33,0.28,0.44,0.44,0.5,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">laboratory). Maraviroc was initiated after PLEX. No significant </text>
   <text y="556.922" x="62.362,65.359,69.355,73.855,76.357,80.857,83.359,87.859,92.359,94.861,98.857,102.853,105.355,107.605,112.105,115.102,117.352,121.348,123.85,126.352,130.852,133.354,137.35,141.346,143.848,146.098,149.095,155.098,158.095,163.099,165.349,169.849,173.845,177.346,179.596,184.096,188.092,190.594,192.844,195.346,199.846,202.096,206.596,210.592,212.842,216.343,220.339,224.335,228.835" svgx:width="0.33,0.44,0.5,0.28,0.5,0.28,0.5,0.5,0.28,0.44,0.44,0.28,0.25,0.5,0.33,0.25,0.44,0.28,0.28,0.5,0.28,0.44,0.44,0.28,0.25,0.33,0.67,0.33,0.56,0.25,0.5,0.44,0.39,0.25,0.5,0.44,0.28,0.25,0.28,0.5,0.25,0.5,0.44,0.25,0.39,0.44,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">radiological or clinical IRIS has yet to be seen.</text>
   <text y="567.92" x="62.362,68.815,73.27,78.229,82.18,84.637,89.596,93.052,95.509,99.964,104.923,108.379,111.331" svgx:width="0.72,0.5,0.56,0.44,0.28,0.56,0.39,0.28,0.5,0.56,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Conclusions: </text>
   <text y="567.92" x="113.221,119.674,123.625,128.08,132.031,134.488,138.943,143.398,150.355,154.306,158.761,161.218,163.108,167.563,170.515,172.405,175.357,181.315,184.267,189.226,191.116,193.573,197.029,198.919,202.87,207.325,211.78,215.236,217.693,222.148,226.099,229.051,233.002,237.457,239.347,243.802,247.753,251.704,254.656,256.546,261.001,265.456,267.913,272.368,276.319,279.271,282.727,286.678,289.135,291.025,293.482,297.982" svgx:width="0.72,0.44,0.5,0.44,0.28,0.5,0.5,0.78,0.44,0.5,0.28,0.25,0.5,0.33,0.25,0.33,0.67,0.33,0.56,0.25,0.28,0.39,0.25,0.44,0.5,0.5,0.39,0.28,0.5,0.44,0.33,0.44,0.5,0.25,0.5,0.44,0.44,0.33,0.25,0.5,0.5,0.28,0.5,0.44,0.33,0.39,0.44,0.28,0.25,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Development of IRIS is considered near universal in </text>
   <text y="578.918" x="62.362,67.321,75.277,80.731,83.683,90.136,95.59,101.548,103.753,105.958,110.413,114.364,116.821,119.026,125.479,129.43,131.635,136.09,138.547,143.002,145.207,149.662,154.117,156.574,158.779,163.234,167.689,171.145,175.096,178.048,182.503,186.454,188.659,191.116,193.573,195.778,198.235,202.69,204.895,209.35,213.805,216.757,218.962,221.419,227.872,232.327,234.532,242.488,246.439,249.391,253.342,257.797,260.254,263.206,267.661,271.612,273.817,276.274,279.226,283.177,287.128,289.585,293.536,298.036" svgx:width="0.56,0.89,0.61,0.33,0.72,0.61,0.67,0.25,0.25,0.5,0.44,0.28,0.25,0.72,0.44,0.25,0.5,0.28,0.5,0.25,0.5,0.5,0.28,0.25,0.5,0.5,0.39,0.44,0.33,0.5,0.44,0.25,0.28,0.28,0.25,0.28,0.5,0.25,0.5,0.5,0.33,0.25,0.28,0.72,0.5,0.25,0.89,0.44,0.33,0.44,0.5,0.28,0.33,0.5,0.44,0.25,0.28,0.33,0.44,0.44,0.28,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">PML-NZB, yet we did not observe it in our two Maraviroc treated </text>
   <text y="589.916" x="62.362,66.817,70.768,73.225,75.682,79.633,84.088,86.545,90.001,92.206,94.789,99.748,104.203,107.155,109.612,114.067,118.018,120.97,127.927,132.382,135.334,139.285,141.49,144.064,146.521,150.976,154.927,157.51,161.965,164.917,169.372,173.827,176.401,182.854,186.805,190.261,192.844,199.297,203.248,205.705,208.162,210.736,213.193,217.648,220.105,224.056,227.008,230.959,233.416,237.367,241.822,244.405,248.86,253.315,255.889,260.344,264.799,267.751,270.334,274.789,278.74,281.197,283.654,287.605,292.06,294.517,298.018" svgx:width="0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.25,0.56,0.5,0.33,0.28,0.5,0.44,0.33,0.78,0.5,0.33,0.44,0.25,0.25,0.28,0.5,0.44,0.25,0.5,0.33,0.5,0.5,0.25,0.72,0.44,0.39,0.25,0.72,0.44,0.28,0.28,0.25,0.28,0.5,0.28,0.44,0.33,0.44,0.28,0.44,0.5,0.25,0.5,0.5,0.25,0.5,0.5,0.33,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">patients. Furthermore, the drug was well tolerated by our patients </text>
   <text y="600.914" x="62.362,66.313,70.768,75.223,77.284,81.739,85.69,89.146,91.207,95.662,99.613,103.564,108.019,110.08,113.536,117.991,122.446,128.899,133.354,135.415,137.872,142.327,144.388,148.843,152.794,157.249,161.2,163.261,167.716,172.171,176.626,181.081,183.142,186.598,190.549,193.501,197.452,199.909,204.364,206.425,210.88,213.832,218.287,221.239,223.696,226.153,230.104,232.309,234.208,241.939,245.89,247.951,251.902,256.357,260.812,265.267,269.218,273.169,275.626,279.577,281.638,284.59,289.045,291.997,294.058,298.054" svgx:width="0.44,0.5,0.5,0.25,0.5,0.44,0.39,0.25,0.5,0.44,0.44,0.5,0.25,0.39,0.5,0.5,0.72,0.5,0.25,0.28,0.5,0.25,0.5,0.44,0.5,0.44,0.25,0.5,0.5,0.5,0.5,0.25,0.39,0.44,0.33,0.44,0.28,0.5,0.25,0.5,0.33,0.5,0.33,0.28,0.28,0.44,0.25,0.25,0.94,0.44,0.25,0.44,0.5,0.5,0.5,0.44,0.44,0.28,0.44,0.25,0.33,0.5,0.33,0.25,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">and has been shown to have good safety profile. We advocate for a </text>
   <text y="611.912" x="62.362,66.313,68.77,71.227,75.682,78.139,82.09,86.041,88.498,90.586,93.043,95.995,98.452,102.403,104.86,106.948,111.403,114.355,116.443,118.9,123.355,125.812,129.268,131.356,135.811,138.763,143.218,147.673,149.761,152.218,156.673,158.761,165.214,170.668,176.626,178.714,181.666,183.754,187.705,191.161,194.617,199.072,203.023,205.48,209.431,211.888,215.839,220.294,222.382,227.341,235.297,240.751,242.956,245.044,251.497,255.952,262.405,266.356,270.811,274.762,277.354,279.559,281.647,286.102,290.557,293.014,295.471,297.973" svgx:width="0.44,0.28,0.28,0.5,0.28,0.44,0.44,0.28,0.25,0.28,0.33,0.28,0.44,0.28,0.25,0.5,0.33,0.25,0.28,0.5,0.28,0.39,0.25,0.5,0.33,0.5,0.5,0.25,0.28,0.5,0.25,0.72,0.61,0.67,0.25,0.33,0.25,0.44,0.39,0.39,0.5,0.44,0.28,0.44,0.28,0.44,0.5,0.25,0.56,0.89,0.61,0.25,0.25,0.72,0.5,0.72,0.44,0.5,0.44,0.33,0.25,0.25,0.5,0.5,0.28,0.28,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">clinical trial of this drug in NZB - associated PML. However, until </text>
   <text y="622.91" x="62.362,66.313,68.248,72.199,74.656,77.113,81.568,84.025,87.976,91.927,94.384,96.319,98.776,101.728,104.185,108.136,110.593,112.528,116.479,120.43,124.885,126.82,131.275,135.226,137.161,141.616,144.406,148.861,152.812,157.267,159.724,163.675,167.626,172.081,174.286,176.221,178.678,181.135,183.07,185.527,188.983,190.918,193.375,200.332,204.787,209.242,212.194,214.651,218.602,223.057,225.514,227.449,229.906,234.361,236.296,238.753,243.208,247.159,250.111,254.062,258.013,261.469,265.42,267.355,269.812,274.267,278.218,280.153,284.608,289.063,293.518,298.018" svgx:width="0.44,0.25,0.44,0.28,0.28,0.5,0.28,0.44,0.44,0.28,0.25,0.28,0.33,0.28,0.44,0.28,0.25,0.44,0.44,0.5,0.25,0.5,0.44,0.25,0.5,0.33,0.5,0.44,0.5,0.28,0.44,0.44,0.5,0.25,0.25,0.28,0.28,0.25,0.28,0.39,0.25,0.28,0.78,0.5,0.5,0.33,0.28,0.44,0.5,0.28,0.25,0.28,0.5,0.25,0.28,0.5,0.44,0.33,0.44,0.44,0.39,0.44,0.25,0.28,0.5,0.44,0.25,0.5,0.5,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">a clinical trial can be organized, it is important to increase the body </text>
   <text y="633.908" x="62.362,66.817,69.769,72.37,74.827,77.284,79.741,83.692,86.644,90.595,93.052,97.507,100.459,104.41,107.011,109.468,113.923,117.874,120.331,122.932,127.387,131.842,135.793,140.248,147.205,151.156,155.611,158.068,161.524,164.125,168.076,170.533,172.99,177.445,179.902,183.853,186.31,190.261,194.716,198.172,200.458,203.059,207.01,211.465,215.92,219.871,222.823,225.28,229.231,233.686,237.637,241.588,244.189,250.642,253.099,255.556,260.011,262.612,265.069,269.524,273.475,276.076,280.531,283.987,287.938,290.539,294.994,297.991" svgx:width="0.5,0.33,0.25,0.28,0.28,0.28,0.44,0.33,0.44,0.28,0.5,0.33,0.44,0.25,0.28,0.5,0.44,0.28,0.25,0.5,0.5,0.44,0.5,0.78,0.44,0.5,0.28,0.39,0.25,0.44,0.28,0.28,0.5,0.28,0.44,0.28,0.44,0.5,0.39,0.33,0.25,0.44,0.5,0.5,0.44,0.33,0.28,0.44,0.5,0.44,0.44,0.25,0.72,0.28,0.28,0.5,0.25,0.28,0.5,0.44,0.25,0.5,0.39,0.44,0.25,0.5,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">of literature that documents clinicians’ experience with the use of </text>
   <text y="644.906" x="62.362,70.318,74.269,77.221,81.172,85.627,88.084,91.036,95.491,99.442,101.647,104.104,108.559,110.764,113.221,116.173,120.124,124.075,126.532,128.737,131.194,135.649,139.6,141.805,145.261,151.219,153.424,157.879,160.336,163.288,167.743,171.199,173.404,176.356,178.561,182.512,185.968,189.424,193.879,197.83,200.287,204.238,206.695,210.646,215.101,217.306,220.258,226.216,229.168,234.127" svgx:width="0.89,0.44,0.33,0.44,0.5,0.28,0.33,0.5,0.44,0.25,0.28,0.5,0.25,0.28,0.33,0.44,0.44,0.28,0.25,0.28,0.5,0.44,0.25,0.39,0.67,0.25,0.5,0.28,0.33,0.5,0.39,0.25,0.33,0.25,0.44,0.39,0.39,0.5,0.44,0.28,0.44,0.28,0.44,0.5,0.25,0.33,0.67,0.33,0.56,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Maraviroc to treat the JC virus - associated IRIS.</text>
   <text y="671.906" x="62.362,67.861,72.361,76.861" svgx:width="0.61,0.5,0.5,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">P858</text>
   <text y="682.904" x="62.362,67.861,70.363,73.36,76.357,80.353,84.349,89.353,91.603,96.607,101.107,106.111,109.108,112.105,116.605,119.602,124.102,126.604,128.854,133.354,138.358,141.355,145.351,149.851,157.348,161.344,164.845,167.095,169.597,174.601,176.851,181.855,186.355,189.352,193.852,196.354,198.856,202.852,207.856,215.353,219.853,224.857,227.854,232.354,235.855,239.356,243.856,247.852,250.354,254.854,257.851,261.847,266.851" svgx:width="0.61,0.28,0.33,0.33,0.44,0.44,0.56,0.25,0.56,0.5,0.56,0.33,0.33,0.5,0.33,0.5,0.28,0.25,0.5,0.56,0.33,0.44,0.5,0.83,0.44,0.39,0.25,0.28,0.56,0.25,0.56,0.5,0.33,0.5,0.28,0.28,0.44,0.56,0.83,0.5,0.56,0.33,0.5,0.39,0.39,0.5,0.44,0.28,0.5,0.33,0.44,0.56,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Fifteen non-fatal outcomes in natalizumab-associated </text>
   <text y="693.902" x="62.362,67.861,76.357,82.36,84.862,88.363,94.861,98.362,103.366,106.363,108.613,111.61,116.614,120.61,122.86,126.856,129.853,132.85,136.846,140.842,143.839,147.34,149.59,154.09,157.087,159.337,163.333,167.833,171.829,174.331,178.831,181.081,186.085,188.587,193.087,197.587,202.591,207.091,210.592,213.094,216.595,218.845,223.345,228.349,233.353,235.603,239.599,244.099,248.599,251.101,255.601,258.103,263.107,267.607" svgx:width="0.61,0.94,0.67,0.28,0.39,0.72,0.39,0.56,0.33,0.25,0.33,0.56,0.44,0.25,0.44,0.33,0.33,0.44,0.44,0.33,0.39,0.25,0.5,0.33,0.25,0.44,0.5,0.44,0.28,0.5,0.25,0.56,0.28,0.5,0.5,0.56,0.5,0.39,0.28,0.39,0.25,0.5,0.56,0.56,0.25,0.44,0.5,0.5,0.28,0.5,0.28,0.56,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">PML/IRIS: the effects of early diagnosis and evolving </text>
   <text y="704.9" x="62.362,67.366,71.866,76.366,80.362,82.864,85.114,88.111,93.115,97.111,101.107,105.607,110.611,114.607,119.611,122.608,125.11,129.106,131.356,135.856,140.86,145.864,149.86,154.36,158.86,162.856,167.86,171.856" svgx:width="0.56,0.5,0.5,0.44,0.28,0.25,0.33,0.56,0.44,0.44,0.5,0.56,0.44,0.56,0.33,0.28,0.44,0.25,0.5,0.56,0.56,0.44,0.5,0.5,0.44,0.56,0.44,0.39" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">novel therapeutic approaches</text>
   <text y="715.898" x="62.362,68.86,71.11,76.114,78.616,82.612,85.609,90.109,93.61,98.11" svgx:width="0.72,0.25,0.56,0.28,0.44,0.33,0.5,0.39,0.5,0.28" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">D Stefoski</text>
   <text y="713.47" x="100.612" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="715.99" x="103.537,105.787,108.037,114.04,116.29,122.293,126.289,128.791,132.787,137.287,141.283,145.783,150.283" svgx:width="0.25,0.25,0.67,0.25,0.67,0.44,0.28,0.44,0.5,0.44,0.5,0.5,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, R Balabanov</text>
   <text y="713.47" x="154.782" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="715.99" x="157.707,159.957,162.207,170.208,172.458,178.956" svgx:width="0.25,0.25,0.89,0.25,0.72,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, M Ko</text>
   <text y="713.47" x="183.456" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="715.99" x="186.381,188.631,190.881,194.382,196.632,201.636,204.138,207.135,211.635,216.135" svgx:width="0.25,0.25,0.39,0.25,0.56,0.28,0.33,0.5,0.5,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, J Strong</text>
   <text y="713.47" x="220.635" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="715.99" x="223.56,225.81,228.06,234.063,236.313,242.811,246.807,249.804,254.304,258.3,262.8,267.3,271.296" svgx:width="0.25,0.25,0.67,0.25,0.72,0.44,0.33,0.5,0.44,0.5,0.5,0.44,0.44" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, C Hernandez</text>
   <text y="713.47" x="275.291" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="715.99" x="278.216,280.466" svgx:width="0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, </text>
   <text y="726.988" x="62.36,68.363,70.613,78.614,83.114,85.616" svgx:width="0.67,0.25,0.89,0.5,0.28,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">C Muth</text>
   <text y="724.47" x="90.118" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="726.99" x="93.043,95.293,97.543,105.544,107.794,115.795,119.791,122.788,126.784,131.284,134.281,136.783" svgx:width="0.25,0.25,0.89,0.25,0.89,0.44,0.33,0.44,0.5,0.33,0.28,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, M Mercurio</text>
   <text y="724.47" x="141.283" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="726.99" x="144.208,146.458,148.708,155.206,157.456,160.957,164.953,169.453,173.449" svgx:width="0.25,0.25,0.72,0.25,0.39,0.44,0.5,0.44,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, A Javed</text>
   <text y="724.47" x="177.948" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">2</text>
  </g>
  <path style="fill:none;stroke:rgb(0,0,0);stroke-width:0.44;" d="M310.020 528.310 L343.770 528.310 "/>
  <g begin="text">
   <text y="74.592" x="310.016" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:5.85px;stroke:none;">1</text>
   <text y="77.112" x="312.941,318.44,322.94,326.441,330.941,333.191,339.689,344.189,346.691,350.687,354.683,358.184,361.685,364.187,366.689,370.685,372.935,380.432,384.428,388.928,391.43,395.426,399.926,402.428,404.678,410.681,414.677,419.177,421.679,425.675,429.176,431.426,433.676,441.173,445.673,448.175,450.677,453.179,457.679,460.181,464.177,466.427,470.927,474.923,477.425,481.421,484.922,489.422,492.923,495.425,498.926,501.176,507.179,511.175,515.675,518.177,522.173,525.674" svgx:width="0.61,0.5,0.39,0.5,0.25,0.72,0.5,0.28,0.44,0.44,0.39,0.39,0.28,0.28,0.44,0.25,0.83,0.44,0.5,0.28,0.44,0.5,0.28,0.25,0.67,0.44,0.5,0.28,0.44,0.39,0.25,0.25,0.83,0.5,0.28,0.28,0.28,0.5,0.28,0.44,0.25,0.5,0.44,0.28,0.44,0.39,0.5,0.39,0.28,0.39,0.25,0.67,0.44,0.5,0.28,0.44,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Rush University Medical Center, Multiple Sclerosis Center </text>
   <text y="88.11" x="310.016,314.516,319.016,323.516,325.766,332.264,336.26,340.76,345.26,348.761,351.263,357.761,361.757,366.257,368.759,371.009,375.509,378.011,380.261,386.264,390.26,394.76,398.261,402.761,405.263,409.763,414.263,416.765,420.761,425.261,427.763,430.013,434.513,438.509,441.011,445.007,449.507,453.503,457.499,461.0,463.25,465.5,471.503,476.003,478.505,482.501,487.001,491.501,496.001,498.251,500.501,503.498,508.502,510.752,513.002,519.5,524.0,526.502,529.004,533.0,537.5" svgx:width="0.5,0.5,0.5,0.25,0.72,0.44,0.5,0.5,0.39,0.28,0.72,0.44,0.5,0.28,0.25,0.5,0.28,0.25,0.67,0.44,0.5,0.39,0.5,0.28,0.5,0.5,0.28,0.44,0.5,0.28,0.25,0.5,0.44,0.28,0.44,0.5,0.44,0.44,0.39,0.25,0.25,0.67,0.5,0.28,0.44,0.5,0.5,0.5,0.25,0.25,0.33,0.56,0.25,0.25,0.72,0.5,0.28,0.28,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">and Department of Neurological Sciences, Chicago, IL, United </text>
   <text y="99.108" x="310.016,314.516,317.018,321.518,324.02,328.016,331.517,333.767" svgx:width="0.5,0.28,0.5,0.28,0.44,0.39,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">States, </text>
   <text y="96.592" x="336.017" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:5.85px;stroke:none;">2</text>
   <text y="99.112" x="338.941,345.439,349.939,352.441,356.438,360.434,363.935,367.436,369.938,372.44,376.436,378.686,383.186,385.688,387.938,393.941,398.441,400.943,404.939,409.439,413.939,418.439,420.689,422.939,429.437,433.433,437.933,442.433,445.934,448.436,454.934,458.93,463.43,465.932,468.182,472.682,475.184,477.434,483.437,487.433,491.933,495.434,499.934,502.436,506.936,511.436,515.432,517.682" svgx:width="0.72,0.5,0.28,0.44,0.44,0.39,0.39,0.28,0.28,0.44,0.25,0.5,0.28,0.25,0.67,0.5,0.28,0.44,0.5,0.5,0.5,0.25,0.25,0.72,0.44,0.5,0.5,0.39,0.28,0.72,0.44,0.5,0.28,0.25,0.5,0.28,0.25,0.67,0.44,0.5,0.39,0.5,0.28,0.5,0.5,0.44,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">University of Chicago, Department of Neurology, </text>
   <text y="110.11" x="310.016,316.018,320.518,323.021,327.017,331.517,336.017,340.517,342.767,345.017,348.014,353.018,355.268,357.518,364.016,368.516,371.018,373.52,377.516,382.016,384.266,388.766,391.268,395.768,398.27,402.266" svgx:width="0.67,0.5,0.28,0.44,0.5,0.5,0.5,0.25,0.25,0.33,0.56,0.25,0.25,0.72,0.5,0.28,0.28,0.44,0.5,0.25,0.5,0.28,0.5,0.28,0.44,0.39" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Chicago, IL, United States</text>
   <text y="137.11" x="310.016,316.018,320.518,324.514,329.518,334.018,337.853,342.353,347.357,352.361,357.365,360.362" svgx:width="0.67,0.5,0.44,0.56,0.5,0.44,0.5,0.56,0.56,0.56,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Background: </text>
   <text y="137.11" x="365.122,371.62,376.12,378.37,380.881,385.381,388.378,390.88,394.876,399.376,401.626,404.137,408.637,411.139,414.641,418.637,423.137,425.639,428.141,432.641,437.141,439.391,441.902,446.402,449.399,451.649,454.16,457.157,461.153,463.655,467.651,470.153,472.403,474.914,479.414,483.914,488.414,492.914,495.911,498.413,502.913,507.413,509.915,513.416,515.918,518.42,522.416,524.666,527.177,531.677,534.674,538.67,541.172,545.672" svgx:width="0.72,0.5,0.25,0.55,0.5,0.33,0.28,0.44,0.5,0.25,0.55,0.5,0.28,0.39,0.44,0.5,0.28,0.28,0.5,0.5,0.25,0.55,0.5,0.33,0.25,0.55,0.33,0.44,0.28,0.44,0.28,0.25,0.55,0.5,0.5,0.5,0.5,0.33,0.28,0.5,0.5,0.28,0.39,0.28,0.28,0.44,0.25,0.55,0.5,0.33,0.44,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">An often disabling or fatal opportunistic brain </text>
   <text y="148.108" x="310.016,312.518,317.018,320.015,324.011,328.007,330.509,333.011,337.511,342.011,344.936,348.932,352.928,357.428,360.929,364.925,369.425,371.675,372.35,376.85,381.35,384.275,386.777,391.277,395.273,398.198,401.699,406.199,410.699,415.199,417.449,418.124,424.127,428.627,433.127,437.627,440.129,444.629,449.129,453.629,457.625,464.627,466.877,467.552,472.052,474.554,477.551,482.051,485.552,488.477,491.474,494.975,500.978,507.476,510.473,512.723,514.973,515.648,520.148,523.145,527.645,532.145,535.142,539.138,542.639" svgx:width="0.28,0.5,0.33,0.44,0.44,0.28,0.28,0.5,0.5,0.25,0.44,0.44,0.5,0.39,0.44,0.5,0.25,0.55,0.5,0.5,0.25,0.28,0.5,0.44,0.25,0.39,0.5,0.5,0.5,0.25,0.55,0.67,0.5,0.5,0.5,0.28,0.5,0.5,0.5,0.44,0.78,0.25,0.55,0.5,0.28,0.33,0.5,0.39,0.25,0.33,0.39,0.67,0.72,0.33,0.25,0.25,0.55,0.5,0.33,0.5,0.5,0.33,0.44,0.39,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">infection caused by the John Cunningham virus (JCV), progres-</text>
   <text y="159.106" x="310.016,313.517,316.019,320.519,324.515,326.765,327.881,334.883,339.383,341.885,344.387,346.889,349.886,354.386,358.382,362.378,364.88,367.13,368.246,370.748,374.744,379.244,383.744,388.244,392.24,396.74,400.736,404.732,409.232,413.732,417.728,420.23,424.73,429.23,433.226,435.728,440.228,444.728,446.978,448.094,451.091,456.095,464.096,469.595,472.592,474.842,475.958,480.458,484.454,488.45,492.95,495.947,499.448,501.698,502.814,505.316,509.816,512.066,513.182,515.684,522.686,529.688,534.188,538.688,542.684" svgx:width="0.39,0.28,0.5,0.44,0.25,0.55,0.78,0.5,0.28,0.28,0.28,0.33,0.5,0.44,0.44,0.28,0.25,0.55,0.28,0.44,0.5,0.5,0.5,0.44,0.5,0.44,0.44,0.5,0.5,0.44,0.28,0.5,0.5,0.44,0.28,0.5,0.5,0.25,0.55,0.33,0.56,0.89,0.61,0.33,0.25,0.55,0.5,0.44,0.44,0.5,0.33,0.39,0.25,0.55,0.28,0.5,0.25,0.55,0.28,0.78,0.78,0.5,0.5,0.44,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">sive multifocal leukoencephalopathy (PML) occurs in immune-</text>
   <text y="170.104" x="310.016,314.012,318.512,325.514,330.014,333.011,337.511,344.513,347.015,350.516,354.512,359.012,361.262,363.665,367.166,369.668,373.664,376.166,380.162,383.663,385.913,388.163,390.566,393.068,397.568,401.564,404.066,408.566,413.066,415.568,420.068,424.568,426.818,429.221,431.723,434.72,438.716,442.712,445.214,452.216,456.212,460.712,463.214,465.464,467.867,472.367,475.364,477.614,480.017,487.019,491.519,494.021,496.523,499.025,503.525,506.027,510.023,512.273,514.676,518.177,522.173,524.675,528.671,531.668,536.168,539.669,542.171,545.672" svgx:width="0.44,0.5,0.78,0.5,0.33,0.5,0.78,0.28,0.39,0.44,0.5,0.25,0.55,0.39,0.28,0.44,0.28,0.44,0.39,0.25,0.25,0.55,0.28,0.5,0.44,0.28,0.5,0.5,0.28,0.5,0.5,0.25,0.55,0.28,0.33,0.44,0.44,0.28,0.78,0.44,0.5,0.28,0.25,0.55,0.5,0.33,0.25,0.55,0.78,0.5,0.28,0.28,0.28,0.5,0.28,0.44,0.25,0.55,0.39,0.44,0.28,0.44,0.33,0.5,0.39,0.28,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">compromised states, including treatment of multiple sclerosis </text>
   <text y="181.102" x="310.016,313.013,321.014,326.018,329.015,331.265,337.763,340.265,342.767,347.267,349.517,354.017,358.013,360.515,364.511,367.013,369.515,373.511,378.011,385.013,389.009,393.509" svgx:width="0.33,0.89,0.56,0.33,0.25,0.72,0.28,0.28,0.5,0.25,0.5,0.44,0.28,0.44,0.28,0.28,0.44,0.5,0.78,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">(MS) with natalizumab.</text>
   <text y="192.1" x="322.013,329.789,333.785,336.035,336.854,339.356,342.353,346.349,350.345,352.847,356.843,361.343,363.593,364.412,367.409,369.911,372.908,375.41,379.406,383.402,387.902,390.152,390.971,395.471,399.467,401.969,404.471,408.467,412.967,415.469,418.97,421.22,422.039,428.537,431.039,433.541,438.041,440.291,441.11,449.111,454.115,456.365,458.615,459.434,462.431,464.933,469.433,473.429,475.679,476.498,479.495,482.492,486.992,493.994,496.244,497.063,503.066,507.566,511.067,515.567,517.817,518.636,522.632,527.132,531.632,533.882,534.701,537.203,541.199,545.699" svgx:width="0.94,0.44,0.25,0.55,0.28,0.33,0.44,0.44,0.28,0.44,0.5,0.25,0.55,0.33,0.28,0.33,0.28,0.44,0.44,0.5,0.25,0.55,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.55,0.72,0.28,0.28,0.5,0.25,0.55,0.89,0.56,0.25,0.25,0.55,0.33,0.28,0.5,0.44,0.25,0.55,0.33,0.33,0.5,0.78,0.25,0.55,0.67,0.5,0.39,0.5,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.28,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">We treated fifteen patients with MS, five from Rush and ten </text>
   <text y="203.098" x="310.016,314.012,318.512,325.514,332.516,337.016,341.516,344.018,346.52,351.02,354.017,357.014,361.01,364.007,368.003,371.0,373.997,377.993,382.493,384.743,386.993,387.713,394.211,396.713,399.215,403.715,405.965,406.685,411.689,419.69,424.856,427.106,427.826,432.326,436.322,440.318,444.818,447.815,450.812,453.314,457.814,462.314,464.564,465.284,469.28,472.277,474.779,478.775,481.772,484.022,484.742,489.242,493.742,496.739,501.239,505.739,507.989,508.709,515.711,520.211,524.711,527.213,531.713,535.214,537.464,538.184,542.684,545.681" svgx:width="0.44,0.5,0.78,0.78,0.5,0.5,0.28,0.28,0.5,0.33,0.33,0.44,0.33,0.44,0.33,0.33,0.44,0.5,0.25,0.25,0.55,0.72,0.28,0.28,0.5,0.25,0.55,0.56,0.89,0.61,0.25,0.55,0.5,0.44,0.44,0.5,0.33,0.33,0.28,0.5,0.5,0.25,0.55,0.44,0.33,0.28,0.44,0.33,0.25,0.55,0.5,0.5,0.33,0.5,0.5,0.25,0.55,0.78,0.5,0.5,0.28,0.5,0.39,0.25,0.55,0.5,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">community-referred, with PML occurring after 14-70 months of </text>
   <text y="214.096" x="310.016,314.516,318.512,321.014,325.01,327.512,330.014,334.01,338.51,345.512,349.508,354.008,356.258,358.76,361.757,365.753,369.749,372.251,379.253,383.249,387.749,390.251,393.752,396.002,398.09,402.959,409.457,413.957,416.207,420.707,424.703,429.203,431.453,435.953,438.95,441.452,445.952,448.949,451.199,453.701,460.703,467.705,472.205,476.705,481.205,484.706,489.206,493.706,498.206,501.203,505.199,508.7,512.201,516.197,520.697,523.199,526.7" svgx:width="0.5,0.44,0.28,0.44,0.28,0.28,0.44,0.5,0.78,0.44,0.5,0.25,0.28,0.33,0.44,0.44,0.28,0.78,0.44,0.5,0.28,0.39,0.25,0.25,0.61,0.72,0.5,0.25,0.5,0.44,0.5,0.25,0.5,0.33,0.28,0.5,0.33,0.25,0.28,0.78,0.78,0.5,0.5,0.5,0.39,0.5,0.5,0.5,0.33,0.44,0.39,0.39,0.44,0.5,0.28,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">natalizumab treatments. Two had prior immunosuppressants.</text>
   <text y="225.094" x="310.016,317.018,322.022,325.019,329.015,333.011,336.008,338.51,343.01,347.006,350.507,353.504" svgx:width="0.78,0.56,0.33,0.44,0.44,0.33,0.28,0.5,0.44,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Objectives: </text>
   <text y="225.094" x="355.591,360.46,364.96,367.048,371.548,374.546,378.542,382.043,386.039,390.539,393.041,395.129,399.125,403.625,405.713,409.709,412.211,414.713,417.71,421.211,425.711,428.708,433.208,435.71,440.21,442.712,447.212,451.712,453.8,457.796,462.296,466.796,471.296,474.293,476.795,478.883,483.383,486.38,488.468,492.968,497.468,499.556,504.056,508.052,510.554,513.056,517.052,521.552,524.054,527.555,529.643,536.141,538.643,541.145,545.645" svgx:width="0.61,0.5,0.25,0.5,0.33,0.44,0.39,0.44,0.5,0.28,0.25,0.44,0.5,0.25,0.44,0.28,0.28,0.33,0.39,0.5,0.33,0.5,0.28,0.5,0.28,0.5,0.5,0.25,0.44,0.5,0.5,0.5,0.33,0.28,0.25,0.5,0.33,0.25,0.5,0.5,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.72,0.28,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">To present an all-surviving cohort of 15 patients with </text>
   <text y="236.092" x="310.016,314.516,318.512,321.014,325.01,327.512,330.014,334.01,338.51,345.512,349.508,354.008,357.005,361.001,364.502,368.003,372.503,376.499,379.001,382.997,385.499,389.495,393.995,396.245,397.064,401.564,404.561,409.061,413.561,416.558,420.554,424.055,427.556,430.058,434.558,438.554,440.804,441.623,448.625,453.125,455.627,458.129,460.631,463.628,468.128,472.124,476.12,478.622,480.872,481.691,484.193,488.189,492.689,497.189,501.689,505.685,510.185,514.181,518.177,522.677,527.177,531.173,533.675,538.175,542.675" svgx:width="0.5,0.44,0.28,0.44,0.28,0.28,0.44,0.5,0.78,0.44,0.5,0.33,0.44,0.39,0.39,0.5,0.44,0.28,0.44,0.28,0.44,0.5,0.25,0.55,0.5,0.33,0.5,0.5,0.33,0.44,0.39,0.39,0.28,0.5,0.44,0.25,0.55,0.78,0.5,0.28,0.28,0.28,0.33,0.5,0.44,0.44,0.28,0.25,0.55,0.28,0.44,0.5,0.5,0.5,0.44,0.5,0.44,0.44,0.5,0.5,0.44,0.28,0.5,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">natalizumab-associated progressive multifocal leukoencephalop-</text>
   <text y="247.09" x="310.016,314.012,316.514,321.014,325.514,327.881,330.878,335.882,343.883,349.382,352.379,354.746,357.248,361.748,364.115,370.613,375.113,379.613,386.615,388.982,395.984,399.98,404.48,408.476,412.976,416.972,423.974,427.97,432.47,434.972,437.339,440.84,443.342,446.339,450.335,452.837,456.833,461.333,463.835,467.831,471.332,473.699,477.695,482.195,486.695,489.197,493.697,497.693,502.193,504.56,507.062,511.562,513.929,517.925,520.292,524.288,528.788,531.785,535.781,538.148,542.648,545.645" svgx:width="0.44,0.28,0.5,0.5,0.25,0.33,0.56,0.89,0.61,0.33,0.25,0.28,0.5,0.25,0.72,0.5,0.5,0.78,0.25,0.78,0.44,0.5,0.44,0.5,0.44,0.78,0.44,0.5,0.28,0.25,0.39,0.28,0.33,0.44,0.28,0.44,0.5,0.28,0.44,0.39,0.25,0.44,0.5,0.5,0.28,0.5,0.44,0.5,0.25,0.28,0.5,0.25,0.44,0.25,0.44,0.5,0.33,0.44,0.25,0.5,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">athy (PML) in whom management strategies evolved to a core of </text>
   <text y="258.088" x="310.016,314.012,318.008,321.005,323.507,328.007,330.815,335.315,339.311,341.813,345.809,349.805,352.307,354.809,359.309,363.809,366.617,371.117,375.617,378.425,386.426,392.429,395.426,397.676,400.484,402.986,409.988,416.99,421.49,425.99,430.49,433.991,436.493,438.995,445.997,450.497,452.999,456.995,459.497,461.999,466.499,470.999,473.807,480.305,482.807,485.309,489.809,492.617,495.614,498.116,500.618,505.118,508.115,512.111,515.612,518.114,520.616,527.618,529.868,532.676,536.672,541.172,545.672" svgx:width="0.44,0.44,0.33,0.28,0.5,0.25,0.5,0.44,0.28,0.44,0.44,0.28,0.28,0.5,0.5,0.25,0.5,0.5,0.25,0.89,0.67,0.33,0.25,0.25,0.28,0.78,0.78,0.5,0.5,0.5,0.39,0.28,0.28,0.78,0.5,0.28,0.44,0.28,0.28,0.5,0.5,0.25,0.72,0.28,0.28,0.5,0.25,0.33,0.28,0.28,0.5,0.33,0.44,0.39,0.28,0.28,0.78,0.25,0.25,0.44,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">early detection by MRI, immunostimulation with filgrastim, and </text>
   <text y="269.086" x="310.016,314.012,318.008,322.508,325.01,327.512,332.012,336.512,340.013,342.263,346.259,350.759,357.761,360.263,364.763,367.265,370.766,373.268,376.265,380.261,382.763,385.265,389.765,394.265,396.515,401.015,404.012,406.262,410.258,414.758,417.755,420.257,422.759,426.755,431.255,433.757,438.257,441.758" svgx:width="0.44,0.44,0.5,0.28,0.28,0.5,0.5,0.39,0.25,0.44,0.5,0.78,0.28,0.5,0.28,0.39,0.28,0.33,0.44,0.28,0.28,0.5,0.5,0.25,0.5,0.33,0.25,0.44,0.5,0.33,0.28,0.28,0.44,0.5,0.28,0.5,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">cautious administration of corticoids.</text>
   <text y="280.084" x="310.016,318.332,322.148,324.965,329.789,334.109,338.933,342.254,345.071" svgx:width="0.94,0.44,0.33,0.56,0.5,0.56,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Methods: </text>
   <text y="280.084" x="347.564,352.253,356.573,359.066,365.888,368.21,372.53,374.852,381.673,383.995,387.811,391.628,394.121,396.443,400.763,403.085,407.405,410.221,413.957,416.027,418.52,424.838,428.654,431.147,434.468,436.79,439.607,441.929,446.249,450.065,452.558,455.375,459.695,462.512,465.005,469.325,472.142,475.958,479.774,482.096,484.418,488.738,491.06,494.876,498.692,501.014,503.507,507.827,510.149,513.965,518.285,522.605,526.925,530.246,532.568,535.889,538.382,542.702,545.699" svgx:width="0.61,0.5,0.25,0.78,0.28,0.5,0.28,0.78,0.28,0.44,0.44,0.25,0.28,0.5,0.28,0.5,0.33,0.5,0.25,0.25,0.72,0.44,0.25,0.39,0.28,0.33,0.28,0.5,0.44,0.25,0.33,0.5,0.33,0.25,0.5,0.33,0.44,0.44,0.28,0.28,0.5,0.28,0.44,0.44,0.28,0.25,0.5,0.28,0.44,0.5,0.5,0.5,0.39,0.28,0.39,0.25,0.5,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">To minimize injury, we strive for preclinical diagnosis of </text>
   <text y="291.082" x="310.016,314.84,322.661,327.647,329.456,333.776,338.096,339.905,344.225,348.545,350.867,354.683,357.005,361.325,363.647,367.967,372.287,374.096,376.418,379.234,381.556,384.373,388.189,392.509,396.829,401.15,404.966,407.288,409.096,412.913,415.729,419.546,423.866,426.188,430.004,432.326,434.134,441.956,447.779,450.595,453.917,455.725,459.542,463.862,468.182,469.991,473.807,477.623,481.439,485.255,487.577,491.393,494.21,498.026,500.348,504.164,508.484,510.293,513.614,519.437,525.593,527.402,531.218,533.54,535.862,542.684" svgx:width="0.56,0.89,0.61,0.25,0.5,0.5,0.25,0.5,0.5,0.28,0.44,0.28,0.5,0.28,0.5,0.5,0.25,0.28,0.33,0.28,0.33,0.44,0.5,0.5,0.5,0.44,0.28,0.25,0.44,0.33,0.44,0.5,0.28,0.44,0.28,0.25,0.89,0.67,0.33,0.39,0.25,0.44,0.5,0.5,0.25,0.44,0.44,0.44,0.44,0.28,0.44,0.33,0.44,0.28,0.44,0.5,0.25,0.39,0.67,0.72,0.25,0.44,0.28,0.28,0.78,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">PML by obtaining tri-annual cranial MRIs and accelerated JCV elim-</text>
   <text y="302.08" x="310.016,312.337,316.658,320.474,322.796,325.117,329.438,333.758,335.755,340.076,342.397,346.214,348.211,350.533,357.355,364.177,368.497,372.817,377.137,380.458,382.78,385.102,391.924,396.244,398.566,402.382,404.704,407.026,411.346,415.666,417.664,423.982,426.304,428.626,432.946,434.944,437.761,440.083,442.405,446.725,449.542,453.358,456.679,459.001,461.323,468.145,470.215,472.213,478.531,482.851,485.173,488.989,493.309,495.307,499.123,505.945,510.265,512.587,514.909,517.726,520.048,523.864,527.185,529.183,531.505,535.825,542.647" svgx:width="0.28,0.5,0.44,0.28,0.28,0.5,0.5,0.25,0.5,0.28,0.44,0.25,0.28,0.78,0.78,0.5,0.5,0.5,0.39,0.28,0.28,0.78,0.5,0.28,0.44,0.28,0.28,0.5,0.5,0.25,0.72,0.28,0.28,0.5,0.25,0.33,0.28,0.28,0.5,0.33,0.44,0.39,0.28,0.28,0.78,0.25,0.25,0.72,0.5,0.28,0.44,0.5,0.25,0.44,0.78,0.5,0.28,0.28,0.33,0.28,0.44,0.39,0.25,0.28,0.5,0.78,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">ination via immunostimulation with filgrastim, which amplifies lym-</text>
   <text y="313.078" x="310.016,314.336,318.656,322.976,326.792,331.112,333.434,337.25,339.5,341.084,345.404,348.221,352.541,356.861,361.181,364.997,367.319,369.641,373.961,378.281,380.531,382.115,385.931,390.251,394.571,396.821,398.405,402.221,406.541,410.861,415.181,417.503,421.823,425.639,427.961,430.283,434.099,436.421,438.671,440.255,444.071,448.391,452.711,456.527,459.848,462.17,466.49,470.81,472.88,475.13,476.552,481.871,486.191,490.007,492.257,493.841,496.163,500.483,502.805,505.127,507.449,511.265,513.587,515.837,517.421,521.741,525.557,528.374,530.696,534.512,538.832,541.154,545.654" svgx:width="0.5,0.5,0.5,0.44,0.5,0.28,0.44,0.25,0.55,0.5,0.33,0.5,0.5,0.5,0.44,0.28,0.28,0.5,0.5,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.44,0.5,0.5,0.5,0.28,0.5,0.44,0.28,0.28,0.44,0.28,0.25,0.55,0.44,0.5,0.5,0.44,0.39,0.28,0.5,0.5,0.25,0.25,0.55,0.61,0.5,0.44,0.25,0.55,0.28,0.5,0.28,0.28,0.28,0.44,0.28,0.25,0.55,0.5,0.44,0.33,0.28,0.44,0.5,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">phocyte production and endothelial adhesion. The initial variably </text>
   <text y="324.076" x="310.016,313.832,318.152,322.472,326.288,330.608,332.786,337.106,339.428,343.244,346.565,353.387,357.203,359.381,363.197,367.517,371.333,375.653,379.469,383.789,388.109,391.925,393.995,396.173,400.493,403.31,407.126,409.448,411.626,418.448,422.264,425.081,427.403,431.723,436.043,440.363,442.685,447.005,449.075,451.253,458.075,460.397,463.214,465.536,469.352,473.168,476.984,481.304,483.626,487.946,491.762,493.832,496.01,499.826,504.146,508.466,510.644,517.466,521.282,524.099,527.915,532.235,534.557,537.374,541.694,545.69" svgx:width="0.44,0.5,0.5,0.44,0.5,0.25,0.5,0.28,0.44,0.39,0.78,0.44,0.25,0.44,0.5,0.44,0.5,0.44,0.5,0.5,0.44,0.25,0.25,0.5,0.33,0.44,0.28,0.25,0.78,0.44,0.33,0.28,0.5,0.5,0.5,0.28,0.5,0.25,0.25,0.78,0.28,0.33,0.28,0.44,0.44,0.44,0.5,0.28,0.5,0.44,0.25,0.25,0.44,0.5,0.5,0.25,0.78,0.44,0.33,0.44,0.5,0.28,0.33,0.5,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">added plasma exchange, oral mefloquin, mirtazapine, and maraviroc </text>
   <text y="335.074" x="310.016,313.832,318.152,322.472,324.794,329.114,332.93,337.25,340.04,343.856,347.177,349.967,352.289,356.609,360.425,363.746,367.067,370.883,375.203,377.525,379.847,383.663,385.985,388.055,390.35,396.668,400.988,403.31,405.632,409.448,413.768,418.088,422.408,426.728,429.05,432.371,436.187,440.507,442.829,446.15,448.94,452.756,457.076,461.396,464.186,468.506,472.826,476.642,480.962,485.282,488.099,491.915,495.236,498.557,500.879,505.199,509.015,511.805,515.621,519.941,522.758,525.08,527.402,531.218,535.538,537.86,542.18,545.681" svgx:width="0.44,0.5,0.5,0.28,0.5,0.44,0.5,0.25,0.44,0.39,0.25,0.28,0.5,0.44,0.39,0.39,0.44,0.5,0.28,0.28,0.44,0.28,0.25,0.25,0.72,0.5,0.28,0.28,0.44,0.5,0.5,0.5,0.5,0.28,0.39,0.44,0.5,0.28,0.39,0.25,0.44,0.5,0.5,0.25,0.5,0.5,0.44,0.5,0.5,0.33,0.44,0.39,0.39,0.28,0.5,0.44,0.25,0.44,0.5,0.33,0.28,0.28,0.44,0.5,0.28,0.5,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">evolved as inessential. Anticonvulsants and unaggressive corticoids </text>
   <text y="346.072" x="310.016,313.832,316.648,320.465,322.535,326.351,330.671,337.493,339.815,344.135,346.457,349.778,352.1,355.916,358.733,362.549,366.869,368.939,372.755,375.077,377.147,379.469,383.789,387.605,389.675,393.995,398.315,401.636,405.452,407.774,409.844,414.164,416.981,419.051,423.875,431.696,436.682,438.752,442.568,446.888,451.208,453.278,456.095,461.918,464.735,469.559,471.629,473.699,476.516,480.332,483.653,487.973,491.789,495.605,497.927,500.249,504.569,508.385,510.707,514.442" svgx:width="0.44,0.33,0.44,0.25,0.44,0.5,0.78,0.28,0.5,0.28,0.39,0.28,0.44,0.33,0.44,0.5,0.25,0.44,0.28,0.25,0.28,0.5,0.44,0.25,0.5,0.5,0.39,0.44,0.28,0.25,0.5,0.33,0.25,0.56,0.89,0.61,0.25,0.44,0.5,0.5,0.25,0.33,0.67,0.33,0.56,0.25,0.25,0.33,0.44,0.39,0.5,0.44,0.44,0.28,0.28,0.5,0.44,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">are administered at the onset of PML and IRIS, respectively.</text>
   <text y="357.07" x="310.016,316.513,320.509,324.01,329.014,331.517,334.514,338.015,341.012" svgx:width="0.72,0.44,0.39,0.56,0.28,0.33,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Results: </text>
   <text y="357.07" x="343.505,349.004,353.504,357.5,360.497,364.493,366.986,373.484,377.48,380.477,384.473,386.966,391.466,395.966,398.459,401.456,405.452,407.954,411.95,414.452,416.954,419.456,421.958,425.954,429.455,431.705,434.198,442.199,448.202,451.199,453.692,458.192,460.694,464.195,468.191,472.691,477.191,481.187,484.184,488.18,492.68,495.173,499.169,502.67,507.17,514.172,518.672,521.174,525.674,532.676,536.672,539.174,541.676,545.672" svgx:width="0.61,0.5,0.44,0.33,0.44,0.25,0.72,0.44,0.33,0.44,0.25,0.5,0.5,0.25,0.33,0.44,0.28,0.44,0.28,0.28,0.28,0.28,0.44,0.39,0.25,0.25,0.89,0.67,0.33,0.25,0.5,0.28,0.39,0.44,0.5,0.5,0.44,0.33,0.44,0.5,0.25,0.44,0.39,0.5,0.78,0.5,0.28,0.5,0.78,0.44,0.28,0.28,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">There were no fatalities. MRI discovered asymptomatic </text>
   <text y="368.068" x="310.016,315.02,323.021,328.186,330.544,333.047,337.547,339.905,344.405,346.763,351.263,355.259,357.761,360.263,364.259,368.759,371.261,374.762,377.012,379.208,384.707,389.207,392.204,396.2,400.196,402.554,407.054,411.05,413.552,416.054,420.05,424.55,427.052,430.553,432.911,437.411,441.407,445.907,448.265,450.767,455.267,457.769,460.271,462.773,466.769,469.271,471.773,476.273,478.631,483.131,487.127,491.627,495.623,498.125,500.627,505.127,509.123,511.481,517.484,522.488,527.492,529.85,533.351,539.354,545.69" svgx:width="0.56,0.89,0.61,0.25,0.28,0.5,0.25,0.5,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.25,0.61,0.5,0.33,0.44,0.44,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.5,0.44,0.5,0.25,0.28,0.5,0.28,0.28,0.28,0.44,0.28,0.28,0.5,0.25,0.5,0.44,0.5,0.44,0.28,0.28,0.5,0.44,0.25,0.67,0.56,0.56,0.25,0.39,0.67,0.72,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">PML in 4 patients. Three patients had initially negative CSF JCV </text>
   <text y="379.066" x="310.016,314.516,319.52,325.522,331.525,333.775,335.863,340.867,343.37,347.87,349.958,354.458,357.455,359.543,364.043,368.543,370.631,373.628,377.624,381.62,386.12,390.62,394.616,397.613,401.609,406.109,408.197,410.699,415.199,417.287,421.787,425.783,429.284,433.28,435.782,438.284,442.784,446.78,448.859,452.855,457.355,461.855,463.943,468.443,470.531,477.029,479.531,482.033,486.533,488.621,491.618,495.614,499.115,501.617,506.117,510.617,514.613,517.115,519.203,523.703,527.699,530.696,533.198,537.194,539.696,542.198,545.699" svgx:width="0.5,0.56,0.67,0.67,0.25,0.25,0.56,0.28,0.5,0.25,0.5,0.33,0.25,0.5,0.5,0.25,0.33,0.44,0.44,0.5,0.5,0.44,0.33,0.44,0.5,0.25,0.28,0.5,0.25,0.5,0.44,0.39,0.44,0.28,0.28,0.5,0.44,0.25,0.44,0.5,0.5,0.25,0.5,0.25,0.72,0.28,0.28,0.5,0.25,0.33,0.44,0.39,0.28,0.5,0.5,0.44,0.28,0.25,0.5,0.44,0.33,0.28,0.44,0.28,0.28,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">qPCR. Six of 15 recovered to baseline and 2 with residual deficits </text>
   <text y="390.064" x="310.016,312.518,317.018,319.043,323.543,326.045,330.545,335.045,337.07,340.067,344.567,349.067,353.063,355.565,358.067,362.567,367.067,369.569,374.069,378.569,380.819,382.682,388.181,392.681,396.677,398.702,401.699,405.695,412.697,416.693,419.195,423.695,426.197,430.697,435.197,437.222,441.722,443.747,448.247,452.243,454.745,457.247,461.243,465.743,468.245,471.746,474.077,476.102,480.602,485.102,487.604,491.6,496.1,503.102,507.098,510.599,512.624,519.122,523.118,526.115,530.111,532.136,535.637,538.139,542.639" svgx:width="0.28,0.5,0.25,0.5,0.28,0.5,0.5,0.25,0.33,0.5,0.5,0.44,0.28,0.28,0.5,0.5,0.28,0.5,0.5,0.25,0.25,0.61,0.5,0.44,0.25,0.33,0.44,0.78,0.44,0.28,0.5,0.28,0.5,0.5,0.25,0.5,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.33,0.25,0.5,0.5,0.28,0.44,0.5,0.78,0.44,0.39,0.25,0.72,0.44,0.33,0.44,0.25,0.39,0.28,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">to high functioning. The remaining 7 patients’ outcomes were sig-</text>
   <text y="401.062" x="310.016,314.516,317.018,320.015,322.517,326.513,330.509,335.009,337.511,340.013,344.513,346.763,353.261,357.761,360.758,364.259,368.255,370.505,373.007,377.507,381.503,386.003,388.253,392.753,395.75,399.746,402.743,407.747,415.748,421.247" svgx:width="0.5,0.28,0.33,0.28,0.44,0.44,0.5,0.28,0.28,0.5,0.25,0.72,0.5,0.33,0.39,0.44,0.25,0.28,0.5,0.44,0.5,0.25,0.5,0.33,0.44,0.33,0.56,0.89,0.61,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">nificantly worse than pre-PML.</text>
   <text y="412.06" x="310.016,316.513,321.013,326.017,330.013,332.516,337.52,341.021,343.523,348.023,353.027,356.528,359.525" svgx:width="0.72,0.5,0.56,0.44,0.28,0.56,0.39,0.28,0.5,0.56,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Conclusions: </text>
   <text y="412.06" x="361.451,367.948,372.448,375.445,377.371,384.374,388.874,391.376,393.878,396.38,400.88,403.877,408.377,412.877,417.377,421.373,425.873,427.799,432.299,435.296,439.796,442.298,446.798,450.794,455.294,457.796,459.722,463.718,468.218,472.718,476.219,478.721,482.222,484.724,487.226,491.726,496.226,498.152,502.652,505.649,507.575,511.571,515.567,518.564,521.066,525.566,527.492,532.496,540.497,545.663" svgx:width="0.72,0.5,0.33,0.25,0.78,0.5,0.28,0.28,0.28,0.5,0.33,0.5,0.5,0.5,0.44,0.5,0.25,0.5,0.33,0.5,0.28,0.5,0.44,0.5,0.28,0.25,0.44,0.5,0.5,0.39,0.28,0.39,0.28,0.28,0.5,0.5,0.25,0.5,0.33,0.25,0.44,0.44,0.33,0.28,0.5,0.25,0.56,0.89,0.61,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Our multipronged protocol consisting of early PML </text>
   <text y="423.058" x="310.016,314.516,318.512,321.014,325.01,329.006,331.508,334.01,338.51,343.01,345.377,348.374,352.874,355.376,357.878,362.378,368.876,372.872,377.372,379.739,384.239,388.739,391.106,395.102,402.104,406.604,409.106,412.103,414.605,418.601,422.597,425.099,427.466,434.468,438.464,442.964,446.96,451.46,455.456,462.458,466.454,470.954,473.456,475.823,480.323,483.32,487.82,492.32,496.316,500.816,503.318,507.818,510.185,514.685,517.682,521.678,526.178,530.174,534.674,537.176,541.172,545.672" svgx:width="0.5,0.44,0.28,0.44,0.44,0.28,0.28,0.5,0.5,0.25,0.33,0.5,0.28,0.28,0.5,0.72,0.44,0.5,0.25,0.5,0.5,0.25,0.44,0.78,0.5,0.28,0.33,0.28,0.44,0.44,0.28,0.25,0.78,0.44,0.5,0.44,0.5,0.44,0.78,0.44,0.5,0.28,0.25,0.5,0.33,0.5,0.5,0.44,0.5,0.28,0.5,0.25,0.5,0.33,0.44,0.5,0.44,0.5,0.28,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">detection followed by empirical management probably prevented </text>
   <text y="434.056" x="310.016,313.013,317.009,319.511,323.507,326.009,328.025,332.525,337.025,339.527,343.523,348.023,355.025,359.021,362.522,364.772,366.788,370.784,375.284,379.28,383.78,385.796,388.298,392.798,394.823,399.323,403.319,405.821,408.323,412.319,416.819,419.321,422.822,424.838,431.336,433.838,436.34,440.84,442.856,447.356,451.352,453.854,457.85,462.35,466.346,470.846,472.862,477.362,479.864,483.86,488.36,492.86,497.36,500.861,503.363,506.864,509.114,511.139,516.638,520.634,523.631,526.133,530.633,532.649,536.645,541.145,545.645" svgx:width="0.33,0.44,0.28,0.44,0.28,0.25,0.5,0.5,0.28,0.44,0.5,0.78,0.44,0.39,0.25,0.25,0.44,0.5,0.44,0.5,0.25,0.28,0.5,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.72,0.28,0.28,0.5,0.25,0.5,0.44,0.28,0.44,0.5,0.44,0.5,0.25,0.5,0.28,0.44,0.5,0.5,0.5,0.39,0.28,0.39,0.25,0.25,0.61,0.44,0.33,0.28,0.5,0.25,0.44,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">fatal outcomes, even in patients with delayed diagnosis. Early and </text>
   <text y="445.054" x="310.016,313.013,316.01,320.006,324.506,329.006,333.002,337.502,340.004,342.317,350.318,356.321,359.318,362.819,365.132,369.128,373.628,378.128,380.441,384.437,388.937,395.939,398.441,402.941,405.443,408.944,411.446,414.443,418.439,420.941,423.443,427.943,432.443,434.756,439.256,442.253,444.566,447.563,450.065,452.567,457.067,460.064,464.06,467.561,470.063,472.565,479.567,481.88,484.382,486.884,491.384,495.38,497.882,502.382,504.695,508.691,513.191,517.691,520.193,523.19,525.692,530.192,534.692,537.194,541.19,545.69" svgx:width="0.33,0.33,0.44,0.5,0.5,0.44,0.5,0.28,0.25,0.89,0.67,0.33,0.39,0.25,0.44,0.5,0.5,0.25,0.44,0.5,0.78,0.28,0.5,0.28,0.39,0.28,0.33,0.44,0.28,0.28,0.5,0.5,0.25,0.5,0.33,0.25,0.33,0.28,0.28,0.5,0.33,0.44,0.39,0.28,0.28,0.78,0.25,0.28,0.28,0.5,0.44,0.28,0.5,0.25,0.44,0.5,0.5,0.28,0.33,0.28,0.5,0.5,0.28,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">frequent MRIs and administration of filgrastim likely contributed </text>
   <text y="456.052" x="310.016,312.518,317.018,319.268,320.924,323.921,327.917,332.417,336.917,339.914,343.91,348.41,350.912,354.908,357.158,358.814,361.811,365.807,369.308,373.808,376.31,380.81,383.312,385.814,390.314,394.814,397.064,398.72,403.22,406.217,408.467,410.123,415.127,423.128,428.627,431.129,434.126,440.129,443.126,448.13,450.38,452.036,454.538,459.038,461.288,462.944,467.444,469.694,471.35,475.85,478.847,481.097,482.753,487.253,491.753,494.003,495.659,500.159,504.155,506.657,509.159,513.155,517.655,520.157,523.658,525.908,528.158,529.652,535.151,539.651,542.153,545.654" svgx:width="0.28,0.5,0.25,0.55,0.33,0.44,0.5,0.5,0.33,0.44,0.5,0.28,0.44,0.25,0.55,0.33,0.44,0.39,0.5,0.28,0.5,0.28,0.28,0.5,0.5,0.25,0.55,0.5,0.33,0.25,0.55,0.56,0.89,0.61,0.28,0.33,0.67,0.33,0.56,0.25,0.55,0.28,0.5,0.25,0.55,0.5,0.25,0.55,0.5,0.33,0.25,0.55,0.5,0.5,0.25,0.55,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.25,0.55,0.61,0.5,0.28,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">to favorable resolution of PML/IRIS in 8 of 15 patients. This </text>
   <text y="467.05" x="310.016,314.012,318.512,323.012,326.009,330.509,334.505,338.501,343.001,345.251,351.749,355.745,358.742,361.739,365.735,370.235,372.737,376.238,378.488,381.485,385.985,388.982,391.484,395.984,399.98,402.977,405.227,409.223,413.723,418.223,420.725,425.225,428.222,432.218,434.72,437.222,441.722,446.222" svgx:width="0.44,0.5,0.5,0.33,0.5,0.44,0.44,0.5,0.25,0.72,0.44,0.33,0.33,0.44,0.5,0.28,0.39,0.25,0.33,0.5,0.33,0.28,0.5,0.44,0.33,0.25,0.44,0.5,0.5,0.28,0.5,0.33,0.44,0.28,0.28,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">approach warrants further exploration.</text>
   <text y="494.05" x="310.016,315.514,320.014,324.514" svgx:width="0.61,0.5,0.5,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">P859</text>
   <text y="505.048" x="310.016,318.512,323.012,328.016,332.516,337.016,339.518,344.522,349.022,351.272,354.269,359.273,363.269,365.519,369.02,375.518,378.02,381.017,385.013,390.017,392.267,395.264,399.26,403.76,411.257,413.507,418.511,423.011,426.008,430.508,433.01,435.512,439.508,444.512,452.009,456.509,461.513,464.51,466.76,469.757,474.761,478.757,481.007,487.505,492.005,495.506,500.51,505.01,510.014,513.011,515.261,517.763,521.264" svgx:width="0.94,0.5,0.56,0.5,0.5,0.28,0.56,0.5,0.25,0.33,0.56,0.44,0.25,0.39,0.72,0.28,0.33,0.44,0.56,0.25,0.33,0.44,0.5,0.83,0.25,0.56,0.5,0.33,0.5,0.28,0.28,0.44,0.56,0.83,0.5,0.56,0.33,0.25,0.33,0.56,0.44,0.25,0.72,0.5,0.39,0.56,0.5,0.56,0.33,0.25,0.28,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Managing the switch from natalizumab: the washout is </text>
   <text y="516.046" x="310.016,315.02,319.52,323.516,328.016,332.012,337.016,341.516,346.52,350.021,352.271,356.771,361.775,366.779,369.029,372.53,377.534,382.034,387.038,389.54,394.544,396.794,401.798,405.794,408.044,412.544,417.044,421.544,424.046,429.05,433.046" svgx:width="0.56,0.5,0.44,0.5,0.44,0.56,0.5,0.56,0.39,0.25,0.5,0.56,0.56,0.25,0.39,0.56,0.5,0.56,0.28,0.56,0.25,0.56,0.44,0.25,0.5,0.5,0.5,0.28,0.56,0.44,0.56" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">hazardous and should be avoided</text>
   <text y="527.044" x="310.016,315.02,317.27,323.272,325.775,330.275,334.271,336.773,341.273" svgx:width="0.56,0.25,0.67,0.28,0.5,0.44,0.28,0.5,0.28" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">F Rinaldi</text>
   <text y="524.592" x="343.775" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="527.112" x="346.699,348.949,351.199,356.203,358.453,363.457,367.453,370.451,372.953,377.453" svgx:width="0.25,0.25,0.56,0.25,0.56,0.44,0.33,0.28,0.5,0.28" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, P Perini</text>
   <text y="524.592" x="379.954" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="527.112" x="382.879,385.129,387.379,393.877,396.127,401.131,405.127,409.627,414.127" svgx:width="0.25,0.25,0.72,0.25,0.56,0.44,0.5,0.5,0.28" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, D Seppi</text>
   <text y="524.592" x="416.629" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="527.112" x="419.554,421.804,424.054,429.058,431.308,439.309,441.811,445.807,450.307,452.809" svgx:width="0.25,0.25,0.56,0.25,0.89,0.28,0.44,0.5,0.28,0.44" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, S Miante</text>
   <text y="524.592" x="456.805" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="527.112" x="459.73,461.98,464.23,469.234,471.484,477.982,481.978,484.48,486.982" svgx:width="0.25,0.25,0.56,0.25,0.72,0.44,0.28,0.28,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, P Gallo</text>
   <text y="524.592" x="491.481" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="535.59" x="310.014" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:5.85px;stroke:none;">1</text>
   <text y="538.112" x="312.941,319.439,323.939,326.441,330.437,334.433,337.934,341.435,343.937,346.439,350.435,352.685,359.183,363.683,367.184,371.684,374.186,376.688,381.188,383.69,385.94,390.44,392.942,395.192,400.691,405.191,409.691,414.191,418.187,422.687,424.937,427.187,432.686,437.186,441.686,446.186,450.182,454.682,456.932,459.182,462.179,464.681,469.181,471.683" svgx:width="0.72,0.5,0.28,0.44,0.44,0.39,0.39,0.28,0.28,0.44,0.25,0.72,0.5,0.39,0.5,0.28,0.28,0.5,0.28,0.25,0.5,0.28,0.25,0.61,0.5,0.5,0.5,0.44,0.5,0.25,0.25,0.61,0.5,0.5,0.5,0.44,0.5,0.25,0.25,0.33,0.28,0.5,0.28,0.44" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">University Hospital of Padova, Padova, Italy</text>
   <text y="565.112" x="310.016,316.019,320.519,324.515,329.519,334.019,337.853,342.353,347.357,352.361,357.365,360.362" svgx:width="0.67,0.5,0.44,0.56,0.5,0.44,0.5,0.56,0.56,0.56,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Background: </text>
   <text y="565.112" x="364.322,370.82,374.816,377.318,381.314,383.816,386.318,390.314,394.814,401.816,405.812,410.312,413.309,415.811,418.808,422.804,426.8,429.302,433.298,437.798,440.048,441.758,444.755,448.751,451.253,455.249,459.749,463.25,465.752,470.252,474.752,477.002,478.712,481.709,485.705,492.707,495.209,497.711,500.213,502.715,507.215,511.715,513.9649999999999,515.675,522.677,527.177,529.679,532.181,534.683,539.183,541.685,545.681" svgx:width="0.72,0.44,0.28,0.44,0.28,0.28,0.44,0.5,0.78,0.44,0.5,0.33,0.28,0.33,0.44,0.44,0.28,0.44,0.5,0.25,0.55,0.33,0.44,0.28,0.44,0.5,0.39,0.28,0.5,0.5,0.25,0.55,0.33,0.44,0.78,0.28,0.28,0.28,0.28,0.5,0.5,0.25,0.55,0.78,0.5,0.28,0.28,0.28,0.5,0.28,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Natalizumab-treated relapsing remitting multiple </text>
   <text y="576.11" x="310.016,313.517,317.513,320.015,324.011,327.008,331.508,335.009,337.511,341.012,343.262,344.639,347.636,353.639,359.642,367.643,372.647,375.644,377.894,379.271,383.771,387.767,390.269,392.771,396.767,401.267,403.769,407.27,409.52,410.897,417.899,421.895,426.395,428.645,430.031,433.028,437.024,441.02,445.016,447.266,448.643,452.639,454.889,456.266,460.766,463.268,467.768,472.268,474.518,475.895,478.892,481.394,484.895,489.395,491.645,493.031,497.531,500.528,502.778,504.155,508.655,511.652,516.152,520.652,523.649,527.645,531.146,534.647,537.149,541.649,545.645" svgx:width="0.39,0.44,0.28,0.44,0.33,0.5,0.39,0.28,0.39,0.25,0.55,0.33,0.67,0.67,0.89,0.56,0.33,0.25,0.55,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.55,0.78,0.44,0.5,0.25,0.55,0.33,0.44,0.44,0.44,0.25,0.55,0.44,0.25,0.55,0.5,0.28,0.5,0.5,0.25,0.55,0.33,0.28,0.39,0.5,0.25,0.55,0.5,0.33,0.25,0.55,0.5,0.33,0.5,0.5,0.33,0.44,0.39,0.39,0.28,0.5,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">sclerosis (RRMS) patients may face a high risk of progressive </text>
   <text y="587.108" x="310.016,317.018,321.518,324.02,326.522,329.024,332.021,336.521,340.517,344.513,347.015,349.265,353.261,355.763,359.759,364.259,368.759,373.259,377.255,381.755,385.751,389.747,394.247,398.747,402.743,405.245,409.745,414.245,418.241,420.743,425.243,429.743,431.993,435.989,438.986,443.99,451.991,457.49,460.487,462.737,464.987,468.488,474.986,478.982,481.484,485.984,489.98,492.482,494.984,498.899,501.149,503.399,507.395,509.897,514.397,516.647,520.643,526.646,532.649,540.65,545.654" svgx:width="0.78,0.5,0.28,0.28,0.28,0.33,0.5,0.44,0.44,0.28,0.25,0.55,0.28,0.44,0.5,0.5,0.5,0.44,0.5,0.44,0.44,0.5,0.5,0.44,0.28,0.5,0.5,0.44,0.28,0.5,0.5,0.25,0.55,0.33,0.56,0.89,0.61,0.33,0.25,0.25,0.55,0.72,0.44,0.28,0.5,0.44,0.28,0.28,0.5,0.25,0.25,0.55,0.28,0.5,0.25,0.55,0.67,0.67,0.89,0.56,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">multifocal leukoencephalopathy (PML). Actually, in RRMS </text>
   <text y="598.106" x="310.016,314.516,318.512,321.014,323.516,327.512,332.012,334.514,338.015,340.265,342.362,344.864,347.861,351.857,355.853,358.355,362.351,366.851,369.101,371.198,374.195,378.695,381.692,383.942,386.039,393.041,397.541,400.538,404.534,406.784,408.881,411.383,415.883,419.879,424.379,426.629,428.726,433.226,437.726,439.976,442.073,449.075,453.575,458.075,460.577,465.077,468.578,470.828,472.925,476.921,481.421,485.921,488.171,490.268,494.768,498.764,503.264,505.766,510.266,514.766,517.016,519.113,523.109,525.359,527.456,530.957,536.96,542.63" svgx:width="0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.55,0.28,0.33,0.44,0.44,0.28,0.44,0.5,0.25,0.55,0.33,0.5,0.33,0.25,0.55,0.78,0.5,0.33,0.44,0.25,0.55,0.28,0.5,0.44,0.5,0.25,0.55,0.5,0.5,0.25,0.55,0.78,0.5,0.5,0.28,0.5,0.39,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.5,0.44,0.5,0.28,0.5,0.5,0.25,0.55,0.44,0.25,0.55,0.39,0.67,0.72,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">patients treated for more then 24 months and having a JCV-</text>
   <text y="609.104" x="310.016,314.012,318.512,321.014,323.516,328.016,332.516,337.016,341.516,343.658,346.16,350.66,355.16,359.156,363.656,365.798,370.874,375.374,377.624,382.124,384.374,386.516,389.018,393.518,397.514,399.656,402.653,405.155,408.656,413.156,415.298,419.798,422.795,424.937,429.941,437.942,443.108,445.25,447.752,451.253,453.395,457.391,461.891,466.391,470.891,473.393,475.535,480.035,482.537,487.037,491.537,496.037,498.287,500.267,505.766,510.266,514.766,518.267,520.517,522.659,527.159,531.155,533.657,537.653,540.155,542.657" svgx:width="0.44,0.5,0.28,0.28,0.5,0.5,0.5,0.5,0.25,0.28,0.5,0.5,0.44,0.5,0.25,0.56,0.5,0.25,0.5,0.25,0.25,0.28,0.5,0.44,0.25,0.33,0.28,0.39,0.5,0.25,0.5,0.33,0.25,0.56,0.89,0.61,0.25,0.28,0.39,0.25,0.44,0.5,0.5,0.5,0.28,0.25,0.5,0.28,0.5,0.5,0.5,0.25,0.25,0.61,0.5,0.5,0.39,0.25,0.25,0.5,0.44,0.28,0.44,0.28,0.28,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">antibody index &gt;1.5, the risk of PML is about 1:125. Thus, natali-</text>
   <text y="620.102" x="310.016,314.012,318.512,325.514,329.51,334.01,336.359,340.859,343.361,346.862,350.858,355.358,359.858,362.36,364.862,369.362,373.862,377.858,380.36,382.862,387.362,391.862,394.211,396.713,400.214,402.563,407.063,409.565,414.065,418.565,421.067,425.567,427.916,431.417,435.917,440.417,444.917,448.913,452.414,454.916,458.912,463.412,465.761,468.263,472.763,475.112,477.614,482.114,486.11,489.611,493.607,495.956,500.456,504.452,506.954,509.456,513.452,517.952,520.454,523.955,526.304,530.3,534.8,539.3,541.649,545.645" svgx:width="0.44,0.5,0.78,0.44,0.5,0.25,0.5,0.28,0.39,0.44,0.5,0.5,0.28,0.28,0.5,0.5,0.44,0.28,0.28,0.5,0.5,0.25,0.28,0.39,0.25,0.5,0.28,0.5,0.5,0.28,0.5,0.25,0.39,0.5,0.5,0.5,0.44,0.39,0.28,0.44,0.5,0.25,0.28,0.5,0.25,0.28,0.5,0.44,0.39,0.44,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.44,0.5,0.5,0.25,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">zumab discontinuation is highly suggested in these patients and a </text>
   <text y="631.1" x="310.016,316.514,320.51,324.011,328.511,333.011,337.511,340.013,342.371,346.871,350.867,353.864,356.366,360.866,365.366,367.724,372.224,375.221,377.579,380.081,384.581,387.578,391.574,395.57,397.928,404.93,409.43,413.93,416.432,420.932,424.433,426.791,429.293,432.794,435.152,439.652,443.648,448.148,452.144,455.141,459.137,461.639,464.141,468.641,470.999,474.995,479.495,483.995,488.495,490.997,494.993,499.493,501.851,506.351,510.347,513.344,517.844,520.841,524.837,527.195,530.696,533.198,537.194,540.191,542.693" svgx:width="0.72,0.44,0.39,0.5,0.5,0.5,0.28,0.25,0.5,0.44,0.33,0.28,0.5,0.5,0.25,0.5,0.33,0.25,0.28,0.5,0.33,0.44,0.44,0.25,0.78,0.5,0.5,0.28,0.5,0.39,0.25,0.28,0.39,0.25,0.5,0.44,0.5,0.44,0.33,0.44,0.28,0.28,0.5,0.25,0.44,0.5,0.5,0.5,0.28,0.44,0.5,0.25,0.5,0.44,0.33,0.5,0.33,0.44,0.25,0.39,0.28,0.44,0.33,0.28,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">washout period of three months is generally adopted before start-</text>
   <text y="642.098" x="310.016,312.518,317.018,321.518,323.381,327.377,329.24,333.74,337.736,344.234,346.097,349.598,353.594,357.59,362.09,366.59,371.09,372.953,375.455,377.957,382.457,386.453,388.316,390.818,395.318,399.314,402.311,406.307,410.807,414.722,416.972,418.835,425.333,429.833,436.331,440.327,444.827,448.823,451.46,453.71,455.573,463.574,468.578,470.441,473.438,477.434,481.43,485.426,487.928,490.43,494.93,498.926,501.428,503.93,508.43,512.93,514.793,519.293,523.289,526.79,528.653,533.153,537.149,541.145,545.645" svgx:width="0.28,0.5,0.5,0.25,0.44,0.25,0.5,0.44,0.72,0.25,0.39,0.44,0.44,0.5,0.5,0.5,0.25,0.28,0.28,0.5,0.44,0.25,0.28,0.5,0.44,0.33,0.44,0.5,0.5,0.25,0.25,0.72,0.5,0.72,0.44,0.5,0.44,0.33,0.25,0.25,0.89,0.56,0.25,0.33,0.44,0.44,0.44,0.28,0.28,0.5,0.44,0.28,0.28,0.5,0.5,0.25,0.5,0.44,0.39,0.25,0.5,0.44,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">ing a new second line therapy. However, MS reactivation has been </text>
   <text y="653.096" x="310.016,314.516,319.016,322.517,326.513,329.51,334.01,338.006,342.506,344.756,347.051,351.047,354.548,359.048,363.044,367.04,369.542,373.538,376.04,378.542,383.042,385.337,389.333,392.33,394.832,398.828,401.825,404.12" svgx:width="0.5,0.5,0.39,0.44,0.33,0.5,0.44,0.5,0.25,0.25,0.44,0.39,0.5,0.44,0.44,0.28,0.44,0.28,0.28,0.5,0.25,0.44,0.33,0.28,0.44,0.33,0.25,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">observed, especially after 3</text>
   <text y="653.096" x="408.62" svgx:width="0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">-</text>
   <text y="653.096" x="411.617,416.117,418.412,425.414,429.914,434.414,436.916,441.416,444.917,447.212,451.208,454.205,456.707,460.703,463.7,465.995,468.497,472.997,476.993,479.288,481.79,485.786,489.287,491.789,494.084,498.584,503.084,506.585,510.581,512.876,517.376,520.373,522.668,527.168,531.164,533.666,537.662,540.164,542.666" svgx:width="0.5,0.25,0.78,0.5,0.5,0.28,0.5,0.39,0.25,0.44,0.33,0.28,0.44,0.33,0.25,0.28,0.5,0.44,0.25,0.28,0.44,0.39,0.28,0.25,0.5,0.5,0.39,0.44,0.25,0.5,0.33,0.25,0.5,0.44,0.28,0.44,0.28,0.28,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">4 months after the last dose of natali-</text>
   <text y="664.094" x="310.016,314.012,318.512,325.514,329.51,334.01,336.26,338.51,339.194,342.191,346.187,348.689,352.19,354.692,359.192,363.692,365.942,366.626,370.622,375.122,379.622,383.618,387.614,390.611,395.111,397.361,398.045,400.547,405.047,409.043,411.545,413.795,414.479,416.981,421.481,425.477,427.727,428.411,434.909,438.905,442.406,446.906,451.406,455.906,458.408,460.658,461.342,468.344,472.34,476.84,479.09,479.774,483.77,488.27,492.77,497.27,500.771,504.767,507.017,507.701,512.201,516.197,518.699,521.201,525.197,529.697,532.199,535.7,537.95,538.634,541.136,545.636" svgx:width="0.44,0.5,0.78,0.44,0.5,0.25,0.25,0.55,0.33,0.44,0.28,0.39,0.28,0.5,0.5,0.25,0.55,0.44,0.5,0.5,0.44,0.44,0.33,0.5,0.25,0.55,0.28,0.5,0.44,0.28,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.72,0.44,0.39,0.5,0.5,0.5,0.28,0.25,0.55,0.78,0.44,0.5,0.25,0.55,0.44,0.5,0.5,0.5,0.39,0.44,0.25,0.55,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.55,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">zumab, raising concern that the washout may expose patients to </text>
   <text y="675.092" x="310.016,313.517,317.513,322.013,326.009,329.006,333.002,335.252,338.249,342.245,344.747,348.743,353.243,356.744,360.74,364.241" svgx:width="0.39,0.44,0.5,0.44,0.33,0.44,0.25,0.33,0.44,0.28,0.44,0.5,0.39,0.44,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">severe relapses.</text>
   <text y="686.09" x="310.016,317.198,322.382,325.559,329.735,333.911,337.088,339.77,344.45,348.626,352.307,355.484" svgx:width="0.78,0.56,0.33,0.44,0.44,0.33,0.28,0.5,0.44,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Objectives: </text>
   <text y="686.09" x="358.265,363.314,367.994,370.775,374.951,379.631,383.807,386.489,391.169,395.345,398.027,402.203,404.633,407.414,410.096,414.776,417.557,421.733,424.514,427.196,431.372,434.387,439.067,443.243,446.024,450.2,454.88,459.56,464.24,467.417,470.099,472.88,477.56,480.737,483.518,491.699,496.883,499.664,504.344,508.52,511.202,513.884,518.06,522.74,525.422,529.103,531.533,534.314,536.996,541.676,545.672" svgx:width="0.61,0.5,0.25,0.44,0.5,0.44,0.28,0.5,0.44,0.28,0.44,0.25,0.25,0.28,0.5,0.25,0.44,0.25,0.28,0.44,0.33,0.5,0.44,0.25,0.44,0.5,0.5,0.5,0.33,0.28,0.25,0.5,0.33,0.25,0.89,0.56,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.25,0.28,0.5,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">To evaluate, in a large cohort of MS patients, the </text>
   <text y="697.088" x="310.016,313.238,315.965,319.691,324.416,326.666,329.87,334.091,338.816,343.541,345.791,348.995,351.722,354.449,361.676,364.403,369.128,373.853,376.103,379.307,384.032,387.254,389.504,392.708,397.433,400.16,403.886,408.107,412.328,416.054,420.275,422.525,425.729,428.951,433.172,437.393,441.614,444.341,447.068,451.793,456.014,458.741,461.468,466.193,470.918,473.168,476.372,480.593,483.815,486.542,490.763,493.985,496.235,499.439,504.164,508.385,511.112,515.333,518.06,520.787,525.008,529.733,536.96,541.181,545.681" svgx:width="0.33,0.28,0.39,0.5,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.28,0.28,0.78,0.28,0.5,0.5,0.25,0.55,0.5,0.33,0.25,0.55,0.5,0.28,0.39,0.44,0.44,0.39,0.44,0.25,0.55,0.33,0.44,0.44,0.44,0.28,0.28,0.5,0.44,0.28,0.28,0.5,0.5,0.25,0.55,0.44,0.33,0.28,0.44,0.33,0.25,0.55,0.5,0.44,0.28,0.44,0.28,0.28,0.44,0.5,0.78,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">risk and timing of disease reactivation after natalizumab </text>
   <text y="708.086" x="310.016,314.651,317.288,320.924,325.055,329.69,334.325,336.962,339.599,344.234,348.869,353.0,355.637,358.274,362.909,367.544" svgx:width="0.5,0.28,0.39,0.44,0.5,0.5,0.28,0.28,0.5,0.5,0.44,0.28,0.28,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">discontinuation.</text>
   <text y="719.084" x="310.016,318.512,322.508,325.505,330.509,335.009,340.013,343.514,346.511" svgx:width="0.94,0.44,0.33,0.56,0.5,0.56,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Methods: </text>
   <text y="719.084" x="351.047,354.044,358.544,360.794,363.08,365.582,370.082,374.078,376.328,378.614,383.114,387.11,390.107,392.609,397.109,401.609,403.859,406.145,414.146,418.142,421.139,425.135,429.635,431.885,434.171,438.671,443.171,447.338,451.838,454.835,459.839,463.835,468.335,470.837,474.833,481.835,486.335,490.331,493.328,495.578,497.864,502.364,506.864,511.364,515.864,518.114,520.364,522.65,527.15,531.146,533.648,537.644,540.146,542.648" svgx:width="0.33,0.5,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.5,0.44,0.33,0.28,0.5,0.5,0.25,0.55,0.89,0.44,0.33,0.44,0.5,0.25,0.55,0.5,0.5,0.5,0.5,0.33,0.56,0.44,0.5,0.28,0.44,0.78,0.5,0.44,0.33,0.25,0.55,0.5,0.5,0.5,0.5,0.25,0.25,0.55,0.5,0.44,0.28,0.44,0.28,0.28,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">In the period March 2011-September 2013, natali-</text>
   <text y="730.082" x="310.016,314.012,318.512,325.514,329.51,334.01,336.26,341.246,347.744,351.74,355.241,357.491,362.477,365.978,368.48,372.98,377.48,381.98,385.976,390.476,392.726,397.712,400.214,404.714,406.964,411.95,416.45,420.95,423.2,428.186,434.189,440.192,448.193,453.197,455.447,460.433,464.933,468.929,471.431,473.933,477.929,482.429,484.931,488.432,490.682,492.932,497.918,503.921,507.917,511.913,515.414,519.914,524.414,527.915,530.165,535.151,538.148,542.648,545.645" svgx:width="0.44,0.5,0.78,0.44,0.5,0.25,0.55,0.72,0.44,0.39,0.25,0.55,0.39,0.28,0.5,0.5,0.5,0.44,0.5,0.25,0.55,0.28,0.5,0.25,0.55,0.5,0.5,0.25,0.55,0.67,0.67,0.89,0.56,0.25,0.55,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.25,0.55,0.67,0.44,0.44,0.39,0.5,0.5,0.39,0.25,0.55,0.33,0.5,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">zumab was stopped in 66 RRMS patients. Reasons for </text>
  </g>
 </g>
</svg>
